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palavras-chave 
 
Incorporação de erros durante a síntese proteica; proteínas aberrantes; 
controlo de qualidade de proteínas; resposta ao stress; alterações 
transcripcionais  
 
A síntese proteica é um mecanismo sujeito a uma apertada regulação, pois a 
manutenção de funções celulares essenciais está dependente da fidelidade 
deste processo. Em condições fisiológicas normais podem ocorrer erros, a 
uma frequência de aproximadamente 10-4 erros por codão descodificado. Este 
nível de erro é tolerado pelas células, mas quando a frequência destes 
aumenta, os mecanismos de controlo de qualidade das proteínas podem falhar 
levando à acumulação de proteínas aberrantes (misfolded) que tendem a 
formar agregados tóxicos, podem comprometer a viabilidade celular, alterar a 
homeostasia e levar ao desenvolvimento de doenças.  
Com o objectivo de elucidar os mecanismos de resposta à acumulação de 
erros durante a síntese proteica e entender como o aumento de proteínas 
aberrantes pode levar ao desenvolvimento de doenças e degeneração celular, 
foram utilizadas células HEK293FT expostas a canavanina e azetidine-2-
carboxylic acid (AZC), análogos da arginina e prolina respectivamente. A 
incorporação destes análogos de aminoácidos leva a uma síntese proteica 
aberrante e origina proteínas que tendem a agregar e ter consequências 
tóxicas para as células. No nosso estudo observámos que a incorporação de 
análogos de aminoácidos levou a uma diminuição ligeira da viabilidade celular, 
assim como levou ao aumento do número de células nas fases G2/M e S do 
ciclo celular. Também foi detectado um aumento de proteínas conjugadas com 
ubiquitina, não se observando alteração na actividade do proteasoma. Isto 
pode indicar que a este nível de erro a que as células estão sujeitas, os 
mecanismos de controlo de qualidade de proteínas estão a ser activados de 
forma a evitarem a agregação proteica. Através das análises ao transcriptoma 
observou-se que os genes cuja expressão diminuiu estão relacionados com a 
matriz extracelular e adesão celular e os genes cuja expressão aumentou, 
estão envolvidos na regulação negativa da transcrição e na resposta a 
proteínas aberrantes.  
Este estudo permitiu adquirir novos conhecimentos acerca da resposta celular 
à incorporação de erros durante a síntese proteica, através da análise de 
alterações transcripcionais causadas pelo stress proteotóxico. As células 
HEK293FT são um bom modelo de estudo para compreender as bases 
moleculares de doenças humanas originadas por uma síntese proteica 
aberrante.  
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abstract 
 
 
Protein synthesis is tightly regulated and fidelity in this process is 
essential for maintenance of essential cellular functions. Under normal 
physiological conditions errors can occur, at frequencies around 10-4 errors per 
codon decoded. This level of mistranslation can be tolerated by cells. When the 
frequencies of errors increase mechanisms of protein quality control can fail 
leading to accumulation of misfolded proteins, which are more prone to form 
toxic aggregates, can compromise cell viability, disrupt cellular homeostasis 
and lead to the development of diseases.  
 
In order to elucidate how cells respond to mistranslation and 
understand how protein accumulation can cause disease and cell 
degeneration, we exposed human HEK293FT cells to canavanine and 
azetidine-2-carboxylic acid (AZC) which are analogues of arginine and proline, 
respectively. Their misincorporation into proteins leads to erroneous protein 
synthesis, misfolding and likely to protein aggregation. Such mistranslation 
event decreased slightly cellular viability and increased the number of cells 
arrested in G2/M and S phases of cell cycle. In HEK293FT cells was detected 
an increase in proteins conjugated with ubiquitin, without altering proteasome 
activity, which may indicate that at this level of mistranslation, protein quality 
control mechanisms are active to counteract the formation of protein 
aggregates. Transcriptional analysis showed that down-regulated genes were 
mainly associated with extracellular matrix and cell adhesion and up-regulated 
genes were involved in negative regulation of transcription and response to 
unfolded proteins.  
 
This study provides new insights into the response of human cells to 
mistranslation by giving a global analysis of transcriptional alterations that 
occur in response to proteotoxic stress. HEK293FT cells can be a good model 
to understand the molecular basis of human diseases caused by mRNA 
mistranslation.  
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1.1 The Process of Translation  
 
The genetic information of all the organisms is stored in the genome. This 
information is used to produce proteins at the appropriate time and place (Lodish, Berk et 
al. 2005). The DNA codifies messenger ribonucleic acid (mRNA) through a process called 
transcription. The mRNAs carry the information that cells use to assemble chains of amino 
acids during the process of protein synthesis, which is carried out by the ribosome that 
interprets mRNA information with the aid of transfer ribonucleic acid (tRNA) and 
translation factors  (Lewin 2004). Therefore, ribosomes are important macromolecular 
machines that translate the mRNA code. These machines are composed of ribosomal 
ribonucleic acid (rRNA) and proteins. In eukaryotes, ribosomes are composed by a small 
subunit (40S) and a large subunit (60S). In the small subunit (40S) there are three tRNA 
binding sites: aminoacyl site (A site), peptidyl site (P site) and exit site (E site) (Lodish, 
Berk et al. 2005). 
Translation can be divided into three main steps: Initiation, Elongation and Termination. 
During initiation the 40S subunit joins the mRNA and searches for the initiation codon, 
using the initiator tRNA (tRNAi) as the searching tool. During elongation aminoacyl 
tRNAs enter in the A site of the ribosome, anticodons of acylated tRNA are 
complementary to codons in the mRNA, so decoding takes place in the ribosomal A site. 
The ribosome then translocates through the mRNA and catalyzes peptide bonds between 
amino acids, forming a polypeptide chain. Termination occurs when the ribosome 
encounters a stop codon, which leads to dissociation of the polypeptide chain from the 
ribosome. The ribosomal subunits are dissociated, mRNA and deacylated tRNA are 
released and the components can be recycled for initiation of another round of translation ( 
Figure 1). These translational processes are conserved among of living organisms, but there 
are some differences between bacteria and eukaryotes (Kapp and Lorsch 2004; Lodish, 
Berk et al. 2005). For the purpose of my work I will focus on the process of eukaryotic 
translation.  
 
9 
 
 
 
 
Figure 1. The process of translation in eukaryotes showing the three main steps: Initiation, Elongation 
and Termination. In blue is represented the open reading frame (ORF); eIFs – eukaryotic initiation factors; 
eEFs – eukaryotic elongation factors; eRFs – eukaryotic release factors; Met – methionine [adapted from 
(Scheper, Knaap et al. 2007)]. 
 
 
1.1.1 Initiation  
 
The first step of eukaryotic initiation is the assembly of the ternary complex 
eIF2.GTP.Met-tRNAi. The eIF2 binds GTP which is hydrolyzed to GDP during initiation. 
Because eIF2 has high affinity for GDP, another factor eIF2B is needed to recycle GDP to 
GTP. The ternary complex binds to the small subunit 40S with the help of eIF1, eIF1A and 
eIF3 originating the 43S complex (Kapp and Lorsch 2004).  
The 5’cap of mRNA is recognized by the eIF4F complex, which contains the 
protein eIF4eE that recognizes the terminal 7-methylguanosine of the mRNA 5’end. The 
eIF4B and eIF4H (RNA binding proteins, the second recently discovered in mammalian 
systems) bind to mRNA and unwind secondary structure in the 5’-untranslated region 
(5’UTR) using the ATP dependent action of the eIF4A subunit an RNA-helicase. The 
eIF4E and eIF4A bind to eIF4G, which is thought to act as an adapter protein. Together 
eIFs 4A, 4E and 4G form the eIF4F complex (Kapp and Lorsch 2004).  
The eIF3 which is a giant heteromultimeric complex, and the poly A binding 
protein, which recognizes the 3’-poly A tail, help the assembly of the mRNA in the 43S 
complex. The eIF3 serves as a scaffold to alter the conformation of the 40S subunit, 
allowing easier access for mRNA, while PAB interacts with eIF4G leading to 
circularization of the mRNA, which is thought to stimulate translation by promoting the 
binding of the 43S complex to the mRNA. This complex scans the mRNA from 5’-3’ 
direction, and stops when the Met-tRNAi anticodon recognizes the initiation codon in the 
mRNA. The scanning process is thought to require ATP hydrolysis, although the ATPase 
10 
 
involved has not yet been identified. eIF1 and eIF1A also participate in the scanning 
process. The selection of the initiation codon (AUG) is facilitated by specific surrounding 
nucleotides which form a favorable sequence context (Kapp and Lorsch 2004; Lodish, 
Berk et al. 2005). The best context contains a purine at position -3 and a G a position +4. 
Then occurs the hydrolysis of GTP bound to eIF2, a reaction facilitated by eIF5 a GTPase-
activating protein (GAP). eIF2.GDP releases the Met-tRNAi in the P-site of the small 
subunit (40S) and dissociates from the complex. Some other factors, like eIFs 1, 1A, 3 and 
5, also dissociate at this stage. eIF5B.GTP binds to the complex probably after the release 
of eIF2.GDP.  The large ribosomal subunit 60S joins to 40S.Met-tRNAi.mRNA complex 
and this requires hydrolysis of GTP bound to eIF5B. The eIF5B stabilizes tRNAi and 
facilitates the joining of the two ribosomal subunits. This step is irreversible since the 
ribosomal subunits do not dissociate until the entire mRNA is translated and proteins 
synthesis is terminated. eIF5B.GDP has low affinity for the ribosome so it dissociates from 
the complex (Figure 2) (Kapp and Lorsch 2004). 
 
 
 
Figure 2. Scheme of the first step in Eukaryotic Translation – Initiation. The involvement of some of the 
initiation factors indicated is still controversial, namely Ded1p in the assembly of 43S.mRNA complex, or 
eIF3 in scanning [adapted from (Kapp and Lorsch 2004)].  
 
 
 
 
 
11 
 
1.1.2  Elongation  
 
Elongation starts with a peptidyl-tRNA in the P site, and a vacant A site which 
accepts aminoacyl-tRNA carried in the form of a ternary complex with eEF1A.GTP (Kapp 
and Lorsch 2004). Only the cognate tRNA carrying the correct amino acid, can enter the 
elongation phase because correct anticodon-codon interactions are required for the 
releasing of tRNAs at the A site.  Binding of cognate tRNA to the A site triggers ATP 
hydrolysis which promotes a conformational change in the ribosome that leads to tight 
binding of the aminoacyl-tRNA in the A site and the release of the eEF1A.GDP complex. 
The conformational change in the ribosome also positions the 3’ end of aminoacylated 
tRNA in the A site in proximity to the 3’ end of peptidyl-tRNA in the P site (Lodish, Berk 
et al. 2005). The ribosomal peptidyl transferase center then catalyzes the formation of the 
peptide bond between incoming amino acid and peptidyl-tRNA. This results in the 
formation of deacylated tRNA which moves to the E site during ribosome translocation 
(Kapp and Lorsch 2004). This step is accomplished by eEF2 which hydrolysis GTP and 
facilitates translocation (Lodish, Berk et al. 2005). After translocation the deacylated tRNA 
is located in the E site and the peptidyl-tRNA in the P site. The A site is free to receive 
another aminoacyl-tRNA complexed with eEF1A.GTP and this cycle is repeated untill a 
stop codon arrives at the A site, which activates the process of termination (Figure 3). 
After the hydrolysis of GTP and the release of aminoacyl tRNA, into the ribosome 
eEF1A.GDP is released and is recycled to its GTP-bound form to participate in successive 
rounds of polypeptide elongation. eEF1B, a multifactor complex catalyses this exchange of 
GDP for GTP (Kapp and Lorsch 2004). 
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Figure 3. Translation process. Scheme of Elongation, Termination and Recycling in Eukaryotes (Kapp 
and Lorsch 2004). 
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1.1.3  Termination and Recycling  
 
The presence of a stop codon in the ribosome A site activates the hydrolysis of the 
ester bond that links the polypeptide chain to the P site_tRNA. Hydrolysis is catalyzed by 
the peptidyl transferase center of the ribosome, in response to the activity of class 1 release 
factors. This class of factors has similar structure to that of tRNAs and bind to the 
ribosomal A site, recognizing stop codons directly. The eRF1 has an omnipotent decoding 
capacity as it can promote the hydrolysis of peptidyl-tRNA in response to any of the three 
stop codons (UAA, UAG, UGA). Class 2 release factors are GTPases that stimulate the 
activity of class 1 release factors regardless of which stop codon the class 1 factor has 
engaged. In eukaryotes the class 2 release factors is eRF3 whose activity promotes the 
release of eRF1 from the ribosome following peptidyl-tRNA hydrolysis (Figure 3) (Kapp 
and Lorsch 2004; Lodish, Berk et al. 2005). 
The last stage of translation is the recycling of the various components of the 
ribosome to use them in another round of initiation. In eukaryotes this step remains 
obscure, since little is known about how the ribosomal subunits are dissociated and how 
mRNA and deacylated tRNA are released. Some studies showed that eIF3 can have an anti 
association activity due to induction of a conformational change in the 40S subunit, 
increasing the rate of subunits dissociation as well as lowering the rate of association. The 
close loop model of eukaryotic mRNAs suggests that the 40S subunit is not released. 
Instead, it may be shuttled across or over the poly (A) tail back to the 5’ end of the mRNA. 
This close loop facilitates the reinitiation of translation (Scheper, Knaap et al. 2007). 
  
14 
 
1.2. Genetic code  
 
The genetic code was established in 1960’s, and establishes the rules used by cells 
to translate the DNA information into protein information (Figure 4). This code is based on 
nucleotide triplets (codons), and these codons do not overlap along the mRNA. The 4 
ribonucleotides (adenosine –A, guanine – G, uridine – U and cyclidine – C) can form 64 
possible codons. 61 specify individual amino acids and 3 are stop codons, i.e. do not 
specify amino acids (UAA, UGA and UAG). Some amino acids such as methionine are 
specified by only one codon, but most amino acids are encoded by more than one codon. 
For example leucine and serine are specified by six different codons each. These codons 
that specify the same amino acid are called synonymous codons. The genetic code is 
therefore degenerated because more than one codon can specify the same amino acid 
(Agris 2004; Lewin 2004).  
Many organisms contain fewer tRNAs than the number of codons. In order for 
tRNA to recognize more than one codon the first base in the first position of the anticodon 
must be able to partner alternative bases in the corresponding third position of the codon. 
According to the Wobble hypothesis, the pairing between codon and anticodon at the first 
two codon positions follows the usual rules of base pairing, but exceptional wobbles occur 
at the third position. This explains why multiple codons that specify the same amino acid 
often differ at the third base position only. This is possible because the conformation of the 
tRNA anticodon loop allows some flexibility at the first base of the anticodon (Agris 2004; 
Lewin 2004) 
The first codon of mRNAs in eukaryotic cells is AUG and specifies methionine, 
and the mRNA sequence from the start codon to the stop codon is called open reading 
frame (ORF), which specifies the precise linear sequence of amino acids that form the 
polypeptide chain (Lodish, Berk et al. 2005). 
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Figure 4. The Universal Genetic Code [adapted from (Lodish, Berk et al. 2005)] 
 
 
 
 
1.2.1  tRNAs  
 
tRNAs are “adapter” molecules that match codons to particular amino acids and are 
crucial translation factors that define the genetic code. tRNAs have two crucial properties: 
each tRNA binds a single amino acid (covalently linked) and contains a trinucleotide, the 
anticodon, which is complementary to the codon in mRNA that is assigned to that amino 
acid. The anticodon recognizes the codon via complementary base pairing (Lewin 2004; 
Lodish, Berk et al. 2005).  
These molecules evolved from a single ancestor by duplication and subsequent 
mutations (Lenhard, Orellana et al. 1999). There are about 50-100 tRNAs in animal and 
plant cells and their genes are transcribed by RNA polymerase III. The number of tRNA 
differs from the number of amino acids since many amino acids have more than one tRNA 
to which they can attach and the number of codons in the genetic code since many tRNAs 
can pair with more than one codon (Lewin 2004; Lodish, Berk et al. 2005; Hopper, Pai et 
al. 2010). 
tRNAs are 74-95 nucleotides long and have common secondary and tertiary 
structures. The function of tRNA depends on their precise three-dimensional structure. In 
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solution these molecules can fold into a secondary structure that resembles a cloverleaf 
(Figure 5) (Lewin 2004; Lodish, Berk et al. 2005). 
 
 
 
 
Figure 5. The Alanine tRNA (tRNAAla) from yeast - secondary structure: cloverleaf  (Lodish, Berk et al. 
2005) 
 
 
In this structure, complementary base pairing forms stem-loops which are the arms 
of the tRNA. There are four major arms: the acceptor arm, the TΨC arm, the anticodon 
arm and the D arm. The acceptor arm consists of a base-paired stem ending in an unpaired 
sequence with a free at 2’- or 3’-OH. This group can link the amino acid. The TΨC arm 
has a sequence of timine, pseudouridine (modified base) and cytosine. The anticodon arm 
contains the anticodon triplet in the center of the loop and the D arm is characterized by the 
presence of the modified base dihydrouridine. There is also an extra arm located between 
the TΨC and the anticodon arms whose length can vary between 3 to 21 bases. In all 
tRNAs the 3’end has the sequence CCA, which is added after synthesis and processing of 
the tRNAs are complete (Lewin 2004; Nakanishi and Nureki 2005).  
tRNAs can be divided in two classes (class I and II) according to the length of the 
extra arm. Class I tRNAs have a short extra arm, 4-5 nucleotides (almost all tRNAs), while 
class II tRNAs have long extra arm with at least 11 nucleotides. tRNAs with long extra 
arms are phylogenetically well-conserved  and include Leucine tRNAs (tRNAsLeu), Serine 
tRNAs (tRNAsSer) in eukaryotes and Tyrosine tRNAs (tRNAsTyr), tRNAsLeu, tRNAsSer in 
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prokaryotes . The long extra arm may be involved in the recognition of these tRNAs by 
their cognate aminoacyl tRNA synthetases or in discrimination against non-cogante 
synthetases (Lenhard, Orellana et al. 1999). 
Some positions in tRNA are conserved (or invariant). That is, a particular base is 
always found in a particular position. Others are semiconserved (semi-invariant), i.e. 
restricted to one chemical type of base (purine or pyrimidine) (Lewin 2004).  
In all tRNAs, the cloverleaf structure forms a tertiary L-shaped structure which is 
created by hydrogen bonding (Figure 6). There are two functional domains in the L-shaped 
structure which had independent origins, namely the acceptor arm which is at one end of 
the tRNA and the anticodon arm at the other end of the tRNA L-type structure (Lenhard, 
Orellana et al. 1999; Ishitani, Yokoyama et al. 2008) The structure of tRNAs is consistent 
with their role in protein synthesis, for this reason the amino acid (attached to the acceptor 
stem) and the anticodon are at opposite ends of the tRNA L-type structure (Lewin 2004; 
Lodish, Berk et al. 2005).  
 
 
 
 
Figure 6. Three-dimentional model of the tRNAs: L-shape (Lodish, Berk et al. 2005) 
 
 
Aminoacyl-tRNA synthetases (aaRSs) are the enzymes responsible for the 
attachment of the amino acid to the tRNA. The aaRS recognize their cognate tRNAs 
trough a limited number of nucleotide residues called identity determinants, which are 
commonly located in the tRNA anticodon, the acceptor stem and the associated 
“discriminator” base at position 73. The extra arm may also contain identity elements for 
tRNA recognition. Each family of tRNAs has a specific discriminator base. For example, 
all tRNAsSer  have G73 and all tRNAsLeu have A73 discriminator bases (Asahara, Himeno et 
al. 1993; Lenhard, Orellana et al. 1999). Recent studies revealed that major identity 
18 
 
determinants are conserved during evolution, but minor identity elements often change 
(Lenhard, Orellana et al. 1999; Sekine, Nureki et al. 1999). The tRNA recognition system 
may also involve identity anti-determinants which are responsible for preventing their 
recognition by non-cognate aaRSs.  
Recent discoveries indicate that tRNAs can have additional roles beyond 
participation in protein synthesis. For example, some tRNAs may be involved in the 
control of apoptosis (programmed cell death), through binding to cytochrome c, a molecule 
that when released from the mitochondria is responsible for the initiation of the intrinsic 
apoptotic pathway (Raam and Salvesen 2010).  The tRNA molecules can also be 
precursors of other small non-coding RNAs. Indeed, studies in HeLa cells identified highly 
abundant small RNA fragments that were derived from mature tRNAs processed by 
enzymes responsible for formation of small regulatory RNAs (Cole, Sobala et al. 2009; 
Miyoshi, Miyoshi et al. 2010).  
 
1.2.3 Aminoacyl-tRNA synthetases (aaRSs) 
 
Before translation, amino acids must be attached to their cognate tRNAs by aaRSs. 
These enzymes establish therefore the genetic code by matching amino acids with tRNA 
anticodons (Pouplana and Schimmel 2001a; Schimmel 2008). These ancient enzymes are 
ubiquitously expressed and universally distributed across the phylogenetic tree suggesting 
that they are among the oldest polypeptide families (Pouplana and Schimmel 2001b; 
O’Donoghue and Luthey-Schulten 2003); and are intimately tied to the historical 
development of the genetic code (Pouplana and Schimmel 2001b; O’Donoghue and 
Luthey-Schulten 2003; Park, Schimmel et al. 2008).  
Each aaRS recognizes and activates a single amino acid through a universally 
conserved two-step mechanism. In the first step (1) the amino acid (aa) is condensed with 
adenosine triphosphate (ATP) forming a tighly bound aminoacyl adenylate. This reaction 
is accompanied by the release of inorganic pyrophosphate (PPi). In the second step (2) the 
activated amino acid is transferred to the 3’ end of tRNA and originates aminoacyl-tRNA 
(aa-tRNA) releasing adenosine monophosphate (AMP) (Figure 7) (Schimmel 2008). 
(1) E+ aa +ATPE(aa-AMP)+PPi 
(2) E(aa-AMP)+tRNAE+ aa-tRNA+AMP 
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Figure 7. The aminoacylation reaction (Ling, Reynolds et al. 2009) 
 
 
The aaRSs are divided into two classes (Class I and Class II) which contain 10 
enzymes each. This division in two classes is based on differences in the structural 
topology of their active sites (Eriani, Delarue et al. 1990). Interesting, each subclass 
originated from an ancient and distinct single-domain protein and there is no evidence for 
the existence a common ancestor (Pouplana and Schimmel 2001a).   
Class I aaRSs are generally monomeric and have in their catalytic domain a 
Rossman nucleotide binding fold (Schimmel 2008). They approach tRNA molecules from 
the minor groove of the tRNA acceptor stem and aminoacylate the terminal adenosine (of 
the CCA-3’ terminal acceptor stem) at the 2’-OH position (Sprinzl and Cramer 1975). In 
contrast Class II aaRSs are typically multimeric enzymes and their active sites contain 
seven-stranded antiparallel β-fold with flanking α-helices (Schimmel 2008). They 
approach tRNAs from the major groove and charge the terminal adenosine at the 3’-OH 
position, based on studies carried out in E.coli (Sprinzl and Cramer 1975).  
The aaRSs can be also divided into three subclasses within each class, namely 
Ia,b,c and IIa,b,c. These subclasses represent the enzymes that are more closely related to 
each other based on their mode of binding to the tRNA acceptor stem (Pouplana and 
Schimmel 2001b). Subclasses Ia and IIa catalyze aminoacylation reactions of many of the 
hydrophobic amino acids, while subclasses Ib and IIb capture the carboxyl side-chain 
amino acids and the amidated (NH2) derivates. Subclasses Ic and IIc catalyze 
aminoacylation reactions for aromatic amino acids (Figure 8) (Schimmel 2008).  
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Figure 8. Classes and subclasses of aaRS. LysRS are found in class II, but there are also examples of 
class I LysRS (Schimmel 2008). 
 
 
To ensure accurate aminoacylation, these enzymes have specific determinants that 
are crucial to recognize the cognate tRNA, like Leu-136 in Glutaminyl-tRNA synthetase 
(GlnRS) of E. coli, which is important for tRNA specificity of tRNAGln. The acceptor stem 
of the tRNA and the anticodon sequence are crucial to recognition of the appropriate tRNA 
by this enzyme (Sherman and Söll 1996).  
The active site of aaRSs (during the activation step) preferentially selects the 
cognate amino acid due to differences in the side chain binding energies of the substrate 
(Favorova 1984). Usually the innate specificity for recognition of cognate amino acid-
tRNA pair is often sufficient to ensure correct aminoacylation, but sometimes, when the 
cognate amino acid displays high structural similarity to other non cognate amino acid (for 
example amino acids that differ by a single methyl group), it is difficult for aaRS to 
distinguish them accurately. Wrong amino acids can then be attached to tRNAs and be 
incorporated into proteins, creating mutant proteins. For this reason, some of the aaRSs 
have an important editing activity which can be encoded by a separate active site. This site 
clears the wrong amino acids attached to tRNAs (Nangle, Lagard et al. 2002; Schimmel 
2008).  
Baldwin and Berg (Baldwin and Berg 1966) stimulated the breakdown of 
misactivated Val-AMP on Isoleucyl-tRNA synthetase (IleRS) by adding Isoleucyl tRNA 
(tRNAIle) to cell extracts, indicating an intrinsic proofreading activity (later called editing 
activity) that could prevent misacylation of tRNAIle with valine. Two ways of editing 
activity can occur; pre-transfer editing which occurs after an amino acid has been 
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activated, but before it has been attached to a tRNA. This involves hydrolysis of the 
misactivated aminocyl-adenylate, aa-AMP, and post-transfer editing which occurs after 
attachment of an amino acid to a tRNA and involves hydrolysis of aminoacyl-tRNA (aa-
tRNA) (Ling, Reynolds et al. 2009; Martinis and Boniecki 2009 ).  
Editing decreases the frequency of errors in the translation process and is important 
for translation quality control (Ling, Reynolds et al. 2009). When this activity  is 
compromised, a wrong amino acid can be incorporated into proteins (Schimmel 2008). 
Studies in bacteria, human cell cultures and mice suggest that defects in editing are toxic to 
bacteria and can be associated to serious pathologies in human cells and mice (Ling, 
Reynolds et al. 2009).   
The aaRSs are central to the translation process, but can also form a variety of 
multiprotein complexes which are present in all three domains of life whose functions are 
not yet fully elucidated (Figure 9). The aaRSs can also have noncanonical functions. For 
example, in humans GlnRS has an antiapoptotic function and the lysyl-tRNA synthetase 
(LysRS) is an inflammatory cytokine (Hausmann and Ibba 2008).  
 
 
 
Figure 9. Functions that aminoacyl-tRNA synthetases can acquire in the three domains of life 
(Hausmann and Ibba 2008) 
 
 
Due to the functional versatility of these enzymes, they can be associated with 
various human diseases and be attractive targets for the development of therapeutics. This 
will be topic of discussion in the subchapter Mistranslation and Disease. 
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1.3 Mistranslation  
 
In spite of being a highly accurate process, protein synthesis is not error free. 
Aminoacylation errors are mainly caused by failure of the aaRS to differentiate between 
amino acids with similar chemical properties or by the incorrect recognition of tRNAs. 
Such errors are minimized by the aaRS editing mechanisms and by highly specific tRNA-
aaRS interactions. At the ribosome level four main types of errors can occur, namely 
missense errors, which result in the substitution of one amino acid for another; nonsense 
errors, that cause readthrough of stop codons and produce proteins with extended C-
termini; frameshifting errors, that alter the mRNA reading frame, producing out-of-frame 
truncated proteins; and finally processivity errors, which cause premature termination 
(Farabaugh and Bjork 1999; Moura, Carreto et al. 2009).  
The frequency of global translational error in vivo, ranging from E. coli to 
mammalian cells, is in the order of 10-4 (Gallant and Palmer 1979; Moura, Carreto et al. 
2009; Reynolds, Lazazzera et al. 2010). This physiological frequency of error is mitigated 
by protein quality control systems which destroy mistranslated proteins. Environmental 
conditions (for example amino acid starvation) can influence the fidelity of translation and 
the frequency of translation errors can increase significantly (Gallant and Palmer 1979; 
Moura, Carreto et al. 2009). But, mistranslation occurs at every step of protein synthesis, 
leading to synthesis of aberrant proteins (Reynolds, Lazazzera et al. 2010).  
    As already described, the mechanisms of quality control are responsible for 
maintaining the level of error low, but these mechanisms can be overloaded which may 
have important consequences for the cell. For example in mice an editing defective alanyl-
tRNA synthetase (AlaRS) is responsible for neurodegeneration (loss of Purkinge cells) and 
ataxia (Lee, Beebe et al. 2006 ).  
Surprisingly, certain errors can be tolerated and may even be advantageous. 
Candida spp. contains a tRNACAGSer that can be aminoacylated with serine and leucine 
leading to ambiguous decoding of CUG codons. Candida albicans can tolerate up to 28% 
misincorporation of leucine without compromising the growth rate and in certain 
environmental conditions this increased level of mistranslation in Candida albicans can be 
advantageous (Santos, Cheesman et al. 1999; Gomes, Miranda et al. 2007). Indeed, 
ambiguous cells are able to survive in toxic environments containing cadmium, arsenate 
and hydrogen peroxide (Santos, Cheesman et al. 1999; Miranda, Silva et al. 2006 ). In 
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mammalian cells mistranslation can also be beneficial. Exposure of virus induces high 
level of mistranslation in mammalian cells due to the increased misincorporation of 
methionine at various non-cognate codons. Since methionine residues can protect proteins 
from ROS damage this type of mistranslation protects cells against oxidative stress 
(Levine, Mosoni et al. 1996; Reynolds, Lazazzera et al. 2010).  
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1.4  Protein Misfolding and Protein Quality Control 
 
 After biosynthesis by the ribosome, proteins must be converted into tightly folded 
compact structures in order to function. In cells there are large numbers of auxiliary factors 
that assist in the folding process, as folding catalysts (enzymes that catalyze the correct 
disulfide bond combination) and molecular chaperones (ensure a high degree of folding 
fidelity). The term “folding” refers to the processes by which the newly synthesized protein 
molecule folds into its unique three-dimensional structure (Dobson 2004; Ecroyd and 
Carver 2008; Herczenik and Gebbink 2008).  
Sometimes proteins cannot fold properly, and become unfolded or misfolded. 
Misfolding can be due to amino acid misincorporation resulting from genetic mutations or 
errors in transcription, mRNA processing or translation and it also depends on 
environmental conditions such as increased temperature, high or low pH or oxidative 
agents. Because of the lack of three dimensional arrangement unfolded proteins are 
nonfunctional (Johnston, Ward et al. 1998; Herczenik and Gebbink 2008; Powers and 
Balch 2008). These proteins are destabilized and expose natively hydrophobic residues that 
seek nonpolar surface area in others destabilized proteins, causing protein-protein 
aggregation (Drummond and Wilke 2008).  These aggregates can be unordered amorphous 
aggregates or highly ordered fibrils that are called amyloid fibrils (Johnston, Ward et al. 
1998; Herczenik and Gebbink 2008).  
Misfolded proteins may disrupt cellular membranes and with it ionic balances 
required for viability, by inserting themselves into the phospholipid bilayer. Also, 
misfolded proteins can overload the proteasome, molecular chaperones, and the 
endoplasmatic reticulum (ER), generate ROS, activate the unfolded protein response 
(UPR) and finally lead to cell death through apoptosis (Figure 10). In addition to these 
toxic effects misfolded proteins can also trigger inflammatory responses, as in the case of 
Alzheimer’s disease where neuroinflamation occurs due to local stimulation of 
complement system (Nangle, Motta et al. 2006; Herczenik and Gebbink 2008).  
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Figure 10. Possible consequences of global mistranslation. In this case mistranslation is caused by 
mischarged tRNAs (Nangle, Motta et al. 2006). 
 
 
Protein quality control mechanisms are essential to cells and have evolved to 
supervise folding, counteract aggregation and eliminate misfolded and damaged 
polypeptide chains before they can exert toxic effects. These mechanisms comprise 
molecular chaperones, specialized intracellular proteases and accessory factors that 
regulate the activity of chaperones and proteases or provide communication between the 
various components (Gregersen, Bross et al. 2006).  
After synthesis, proteins interact with chaperones to achieve their three dimensional 
conformation. There are many chaperones that have different functions: folding 
chaperones promote folding; holding chaperones lack ATPase activity and maintain 
solubility and finally unfolding chaperones contain two domains that harbor an ATPase 
and unfold misfolded proteins (Gregersen, Bross et al. 2006). Chaperones recognize 
selectively misfolded proteins and are the first step towards their elimination.  Misfolded 
proteins can be refolded to a functional native state or can be sequestered by chaperones to 
prevent toxic interactions. Some chaperones such as Hsp70 and its cofactor Hsp40, seem to 
alleviate toxicity by sequestering soluble misfolded proteins or by modulating their 
conformation. In Huntington’s disease these chaperones induce conformational 
rearrangements in Hungtintin, a pathogenic protein, and disfavor the accumulation of 
specific soluble polyQ fibril intermediates (Wacker, Zareie et al. 2004 ; Muchowski and 
Wacker 2005).   
26 
 
Proteins that cannot be refolded must be eliminated by proteases. The most 
prominent protease of the cytosol is the proteasome, but there are other proteases that 
belong to the protein quality control system, for example in mitochondria (Gregersen, 
Bross et al. 2006).   
The ubiquitin-proteasome system (UPS) consists of a large number of proteins that 
identify, target and destruct proteins. This system can hydrolyze almost any polypeptide 
chain because it contains three different proteases with complementary activities: 
chymotrypsin-like, trypsin-like and caspase-like activities (Voges, Zwickl et al. 1999).   
These proteases are embedded in a large barrel-shape proteolytic complex, the proteasome 
core 20S. This proteolytic core can only be accessed through gated entrances on either side 
of the proteasome (19S subunits). This compartmentalized structure safeguards the highly 
specific nature of the process and prevents non-specific protein degradation (Dantuma and 
Lindsten 2010).  
Proteins need to be marked for degradation by the proteasome. This is achieved by 
the covalent linkage of a chain of ubiquitin proteins. Specific enzymes, ubiquitin activase 
(E1), ubiquitin conjugases (E2s) and ubiquitin ligases (E3s) are responsible for the linkage 
of the C terminus of the 76 amino acid long ubiquitin polypeptide to the α-NH2 group of an 
internal lysine residue of the substrate. Polyubiquitinated proteins bind to specific ubiquitin 
binding domains (UBD) which are located in the proteasome. Prior to degradation, in the 
proteasome, chains of ubiquitin are disassembled to ubiquitin monomers and the protein is 
unfolded and funneled through the narrow entrance of the proteasome to be hydrolysed 
(Figure 11) (Dantuma and Lindsten 2010).  
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Figure 11.  Protein degradation by the ubiquitin-proteasome system. Ub-ubiquitin; DUB- 
deubiquitylation enzymes(Dantuma and Lindsten 2010).  
 
 
Misfolding proteins residing in the ER can also be degraded by proteasome, a 
process called ER-associated degradation (ERAD). Proteins in the ER are retrotranslocated 
to the cytosol, to be degraded by the UPS (Dantuma and Lindsten 2010).  
If there is an increase in accumulation of misfolded proteins in ER and UPS is 
impaired, cells alleviate stress through the UPR. UPR consists in the transcriptional 
activation of genes required for protein folding, ER expansion ER-Golgi trafficking and 
ERAD, which all act collectively to relieve stress within the ER and reestablish its normal 
function. Translation of mRNAs is also initially inhibited, reducing the influx of new 
proteins into the ER (Haynes, Titus et al. 2004; Xu, Bailly-Maitre et al. 2005 ). Activation 
of UPR can be beneficial to cells, but if it is too prolonged UPR can lead to accumulation 
of ROS via the UPR-regulated oxidative protein folding machinery in the ER or in the 
mitochondria. In this way UPR contributes to cell death, usually apoptosis (Haynes, Titus 
et al. 2004).  
In spite of not being normally considered a mechanism of protein quality control, 
cells can also degrade proteins through autophagy. Autophagy is the generic name used for 
any intracellular process that results in the degradation of cytosolic components inside the 
lysosomes. In these structures there is a complete and irreversible dissociation of the 
substrate into its essential constituents (Cuervo 2004).   
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Autophagy has been linked to some pathologies such as Alzheimer’s disease, 
Parkinson’s disease and different forms of cancer. This process is responsible for 
elimination of altered cytosolic constituents such as aggregated proteins and damage 
organelles and preserves cells from further damage (Larsen and Sulzer 2002). In this way, 
activation of autophagy could play a protective role in early stages of several diseases. 
Once a certain level of intracellular damage is reached, autophagy might instead become 
an efficient way of removing the injured cell from a tissue (Larsen and Sulzer 2002).  
Therefore, cells can control the production quality proteins that constitute the 
proteome by diverse mechanisms. The first lines of protein quality control are the 
molecular chaperones that can refold proteins in the cytosol, ER or mithocondria. Then 
misfolded proteins in the cytosol or ER can be degraded by the ubiquitin-proteasome 
system (Gregersen, Bross et al. 2006). When ER stress occurs UPR is activated to 
counteract accumulation of misfolded proteins and aggregates. Finally misfolded proteins 
and aggregates can also be degraded by autophagy.   
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1.5  Diseases associated with mistranslation   
 
 Diseases have been associated with mistranslation. A clear case is the 
mistranslation associated to mutations in the editing domain of the mouse AlaRS which 
allow the enzyme to charge tRNAAla with serine or glycine. Indeed, the editing is essential 
to deacylate Ser-tRNAAla and Gly-tRNAAla. If these mischarged tRNAs are not cleared, 
serine or glycine will be incorporated instead of alanine, leading to the synthesis of 
misfolded proteins that are extremely toxic to neurons. Mice that have mutant AlaRS loose 
rapidly Purkinje cells in the cerebellum and develop severe ataxia (Park, Schimmel et al. 
2008). 
Mutations in genes encoding aaRSs can also lead to neuropathies as Charcot-Marie-
Tooth (CMT) disease, which is characterized by muscular weakness and atrophy of the 
distal extremities. Genes that encode GlyRS and TyrRS have mutations in CMT patients 
that lead to conformational changes in the structure of these enzymes that prevent efficient 
interaction with the respective tRNAs. At least 10 mutant alleles have been associated to 
defective GlyRS (Xie, Nangle et al. 2007 ; Park, Schimmel et al. 2008).   
Also mutations in tRNAs, specially in mitochondrial tRNA genes, are correlated 
with severe diseases, including fatal cardiopathies, encephalopaties, myophaties, diabetes 
and others. Mioclonic epilepsy with ragged-red fibers (MERRF) and mitochondrial 
myopathy, encephalopathy, lactic acidosis and stroke (MELAS) are the most common 
syndromes correlated with point mutations in mitochondrial tRNA genes.  Eighty percent 
of patients with MELAS carry a maternally inherited A>G mutation in the nucleotide 3243 
in the tRNALeu(UUR) that affects its stability, impairs charging efficiency with Leu and 
prevents taurine modification in the anticodon. An A8344G mutation in the tRNALys 
causes MERF. This mutation affects aminoacylation and taurine modification of the 
wobble nucleotide of the anticodon which is essential for codon-anticodon pairing on the 
ribosome (Florentz and Sissler 2001; Rabilloud, Strub et al. 2002 ; Levinger, Morl et al. 
2004; Scheper, Knaap et al. 2007).  
Ribosome frameshifting can have a potential role in generating aberrant proteins 
such as ubiquitin B (UBB+) and β-amyloid precursor protein (APP+) which are implicated 
in Alzheimer’s and other neurodegenerative diseases. These proteins are called “+1 
proteins” because they have carboxyl-terminal amino acids encoded by an alternative 
reading frame of the mRNA. Aberrant proteins inhibit the function of the proteasome, 
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leading to their accumulation and can form neurofibrillary tangles and neuritic plaques 
(Wills and Atkins 2006 ) .  
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1.6 Cellular stress response due to misincorporation of amino acid 
analogues  
 
There are hundreds of amino acid analogues produced by plants, synthesized in 
vitro or produced in vivo by oxidation of amino acid side-chains (Rodgers and Shiozawa 
2008).     
Certain amino acid analogues can have a similar structure to the natural amino 
acids and can escape detection by the cellular protein synthesis machinery, becoming 
misincorporated into the growing polypeptide chain of proteins. This incorporation leads to 
altered function of the proteins, production of misfolded or unfolded proteins and 
aggregates (Rodgers and Shiozawa 2008).  
The aaRSs can select the correct amino acids, but if an amino acid analogue has a 
similar structure to the natural amino acid it may bind to an aaRS be activated and 
incorporated into proteins (Figure 12) (Richmond 1962).  
Amino acid analogues misincorporation have been studied in bacteria and insects 
(plant amino acids show anti-microbial and insecticidal effects) but have been poorly 
studied in mammalian systems (Hendrickson, Crécy-Lagard et al. 2004; Rodgers and 
Shiozawa 2008).  The response of cells to amino acid analogues depends on several 
factors, namely the efficiency of their transport into the cell; the extent to which the 
analogue satisfies the substrate specificity of the enzyme; the availability of the natural 
amino acid and the extent to which the incorporation of the analogue modifies the structure 
of the proteins and the enzymatic activity (Richmond 1962; Rodgers and Shiozawa 2008).  
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DNA replication and translation mechanisms and  decreased tolerance to heat, radiation 
and other stressors (Worthen, Chien et al. 1998).   
Azetidine-2-carboxylic acid (AZC) can substitute proline (Pro) during protein 
synthesis. It leaks one carbon atom in its ring relative to Pro, which causes reduction of 
thermal stability of proteins and misfolding (Figure 13). Collagen contains large amounts 
of Pro, so is particularly sensitive to the replacement of Pro with AZC (Rodgers and 
Shiozawa 2008). The replacement of Pro with AZC causes growth inhibition of E. coli and 
in yeast it induces protein misfolding and selectively activates the heat shock factor which 
is required for the subsequent G1 arrest of the cell cycle (Trotter, Kao et al. 2002 ; Jhon and 
Kang 2007).  
 
 
 
 
Figure 13. Structure of natural amino acids and respective analogues. a) Natural amino acid Arginine 
and its analogue Canavanine. b) Natural amino acid Proline and its analogue Azetidine (Rodgers and 
Shiozawa 2008). 
 
 
Canavanine only differs from arginine in the structure of its side chain, so it is not 
expected to significantly alter the conformation of the polypeptide backbone into which it 
is incorporated. Therefore treatments with canavanine cause less protein misfolding than 
those with AZC (Trotter, Kao et al. 2002 ).  
The incorporation of amino acid analogues originates modified proteins that tend to 
degrade faster than native proteins in bacterial and human cells and have been shown to 
induce many heat shock proteins (HSPs) (Rodgers and Shiozawa 2008).   
The use of amino acid analogues could therefore be useful to understand the 
response of cells to mistranslation, which mechanisms are required to protect cells against 
the accumulation of damaged proteins and how these damaged proteins can lead to cellular 
Arginine Canavanine  
Azetidine (AZC)  Proline   
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death. Some of these mechanisms have already been identified for yeast but are less well 
studied in human cells (Figure 14).  
 
 
 
 
Figure 14. Incorporation of amino acid analogues can lead to synthesis of aberrant proteins that  
misfold or unfold and activate mechanisms of protein quality control. For example: molecular 
chaperones, ubiquitin-proteasome system or UPR-unfolded protein response, among others. The failures of 
these mechanisms lead to formation of toxic aggregates and unstable proteins which originate many 
responses by the cell to the mistranslation phenomenon. 
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1.7 Aims of the study  
 
The aim of this Master thesis was to study the cellular responses to mistranslation, 
using the human cell line HEK293FT. These cells were exposed to amino acid analogues, 
Azetidine-2-carboxylic acid (AZC) and canavanine, which are known to misincorporate 
into proteins during protein synthesis. This study is important to understand the response of 
human cells to mistranslation and to start unveiling the cellular and molecular mechanisms 
of diseases associated to protein misfolding and aggregation.   
The biological questions addressed here are the following:  
1- Which molecular mechanisms are activated in response to mistranslation? 
2- How is the transcriptional response to mistranslation regulated?  
3- Are HEK293FT cells a good model system to study cell degeneration and 
disease associated to mistranslation? 
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Chapter II – Materials and 
Methods 
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2.1 Materials 
 
 
HEK293FT cells were purchased from Invitrogen (Barcelona, Spain). Dulbecco’s 
modified Eagle’s medium (DMEM) as well as poly-D-lysine, bovine serum albumin 
(BSA), paraformaldehyde, L-canavanine and L-azetidine-2-carboxylic acid (AZC) were 
purchased from Sigma-Aldrich (Sintra-Portugal). Fetal bovine serum (FBS), glutamine, 
trypsin and geneticin (G418) were purchased from Gibco, Invitrogen Life Technologies 
(Barcelona, Spain). The BCA assay kit was purchased from Pierce, as a part of Thermo 
Fisher Scientific (Rockford, Illinois, USA). Propidium Iodide was purchase from 
Cytognos, as a part of the kit Cycloscope B-All for DNA studies. Hoechst 33342 
trihydrochloride trihydrate was purchased from Molecular Probes (Leiden, Netherlands). 
The reagents to perform Oligo Microarrays were purchased from Agilent Technologies 
(Santa Clara, USA). Anti-ubiquitin antibodies were purchased from Dako (Aachen, 
Germany), and normal rabbit IgGs were purchased from Santa Cruz Biotechnology 
(California, USA).  
All other reagents were from Sigma-Aldrich (Sintra-Portugal) or from Merck 
(Darmstadt, Germany). L-canavanine and L-azetidine-2-carboxylic acid (AZC) were kept 
in aqueous stocks. 
  
39 
 
2.2 Methods  
 
2.2.1 Cell Culture 
 
Human embryonic kidney (HEK) 293FT cells were cultured in Dulbecco’s 
Modified Eagle’s Medium (DMEM) with 10% of fetal bovine serum (FBS), 5% geneticin, 
1% L-glutamine and supplemented with non-essential amino acids (10mM). Cells were 
kept in falcon flasks (75cm2) at 37ºC, in a humidified incubator with 5% CO2/95% air.  
 
2.2.2 Preparation of cells and stimulation with AZC and canavanine 
 
Single cell suspensions were obtain by trypsinization (1mL, 5 min at 37ºC) of 
monolayer cultures. Then 5mL of DMEM were added to stop trypsin (0,25%) activity and 
cell suspensions were transferred to a falcon tube. Cell density in the suspensions was 
determined by counting the number of cells using a Neubauer chamber.  
Cells were cultured at the density of 0.3x105cells/cm2 for all the assays, and were 
maintained for 24h before incubation with the drugs for 48h.   
                                                                                                                                             
Day 0 Day 1 Day 3 
Cell culture Addition of drugs Collection of 
the cells 
to perform the 
assays 
 
          
 
2.2.3 Cellular viability assay – MTT  
 
To assess cell viability the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium 
bromide (MTT) reduction test was used. When taken up by living cells, MTT is converted 
from yellow to a water-insoluble blue-colored precipitate, formazan, by mitochondrial 
succinate dehydrogenase and probably by pyridine nucleotide cofactors NADH and 
NADPH in the cytoplasm of metabolically active cells (Wyllie 2009). 
48h of drug exposure 
exposure 
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MTT(1mg/mL) – in sodium buffer with 1mM CaCl2, was added to the cultures 
after 48h of drug exposure, and incubated for 2h30min at 37ºC in humidified incubator 
with 5% CO2/95% air. Formazan crystals were dissolved in 0.04M HCl in isopropanol. 
Solutions were transferred to a 96 multiwell plate to read absorbance in an ELISA plate 
reader Spectra Max plus (Molecular Devices). A plate analyzer with dual wavelength 
measuring system was used, at a test wavelength of 570nm and a reference wavelength of 
620nm. All experiments were carried out in triplicate, and the reduction of MTT was 
expressed in the experimental conditions as percentage of that observed in the control 
cultures (100%).  
 
2.2.4 Fluorescence Microscopy  
 
HEK293FT cells were plated on coverslips (12mm) coated with poly-D-lysine 
(0,1mg/ml). After incubation in the presence or in the absence of the drugs, the cells were 
fixed with 4% paraformaldehyde/4% sucrose for 15 min at room temperature. The cells 
were then washed 3x with phosphate buffered saline (PBS) and stained with the 
fluorescent dye Hoescht 33342 (1 µg/ml in sodium buffer) for 15 min at room temperature. 
The coverslips were mounted on glass slides with Dako mounting medium and examined 
with a Zeiss Axiovert 200 fluorescence microscope (20× objective).  
Hoechst is a permeable DNA stain that binds preferentially to A-T base-pairs. This 
dye is excited by ultraviolet light at around 350nm and emits blue fluorescence. By 
microscopic observation, nuclei of viable and non viable cells can be distinguished. 
Nuclei of viable cells and non viable cells were counted to calculate the percentage 
at each microscopic field. All experiments were carried out in triplicate and the results 
were expressed in percentage of viable or non viable cells for each experimental condition. 
 
2.2.5 Flow Cytometry  
  
 Flow cytometry is a rapid technique that allows characterizing different cells 
properties by analyzing individual cells in a population. Two of the applications of this 
technique are the measurement of cellular DNA content and the analysis of the cell cycle. 
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For these analyses, cells were stained with a fluorescente dye, Propidium Iodide (PI) that 
intercalates between the bases of the DNA with no sequence preference. 
Cells were cultured in a 6 multiwell plate coated with poly-D-lysine. After 48h of 
drug exposure, cell suspensions were obtained by trypsinization of the cells (1mL, 5 min at 
37ºC) and the enzyme was inactivated by 500µL of 1% PBS and 100µL of 10% FBS. Cell 
suspensions were centrifuged (0.2g, 5min at 4ºC) and the supernatant was discarded. The 
pellet was resuspended in 1mL of 1% PBS. The centrifugation step was repeated and the 
pellet was resuspended in 100µL of 1% PBS. Cells were kept at 4ºC until data acquisition 
by the flow cytometer. 
100µL of sample were transferred to cytometer tubes and samples were gently 
aspirated several times with a Pasteur pipette to obtain a cell suspension with minimal cell 
aggregation. 200µL of PI was added to each sample tube. Tubes were incubated 
horizontally in the dark for 15min. Before acquisition each sample was resuspended in 
500µL of 1% PBS. About 20.000 events were acquired in the cytometer FACS Calibur 
(Becton-Dickinson) using Cell Quest software (PMac) and analyzed using ModFitLTTM 
v2.0 software (PMac). The results were expressed in percentage of cells in each phase of 
the cell cycle (G0-G1; G2-M; S) for each experimental condition.  
 
2.2.6 Proteasome activity assay 
 
 Proteasome is responsible for the degradation of proteins that are damaged or not 
necessary for the cell, by proteolysis. The 26S proteasome is an ATP-dependent proteolytic 
complex which contains a core particle (20S) and two regulatory caps (each one 19S). In 
the core, enzymes with specialized activities (chymotripsin-like, trypsin-like and caspase-
like) break down peptide bonds (Dantuma and Lindsten 2010). Proteasome activity can be 
measured using a labeled peptide (Suc-LLVY-AMC) which is cleaved by enzymes with 
chymotrypsin-like activity thereby generating a strong fluorescent signal. 
Cell extracts were prepared to detect proteasome activity in experimental 
conditions. Cells were washed with ice-cold PBS. A lysis buffer (Appendix 1) was added 
to the cells, which were then scraped. The extracts were sonicated and left on ice for 5 min. 
The lysates were then centrifuged at 12000xg for 10 minutes at 4ºC and the supernatants 
recovered. Protein was quantified using the Bio-RAD method, and the extracts were 
diluted in lysis buffer (Appendix 1) to equalize protein concentrations of all samples. 20µg 
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of protein were incubated in a 96 multiwell plate with proteasome activity buffer (in 
duplicate) (Appendix 1) in a final volume of 100µL.  
 The fluorescence intensity was monitored in a Spectra Max (Molecular Devices) 
fluorometer for one hour (measurements in every 5 min), using the wavelengths: 380nm 
excitation and 460nm emission.  
We carried out the experiment four times and proteasome activity was expressed in 
the experimental conditions as the percentage of that observed in the control cultures 
(100%).  
 
2.2.7 Western blot 
 
In order to analyse protein ubiquitination, samples were subjected to sodium 
dodecylsulfate polyacrylamide gel electrophoresis (SDS-PAGE) where protein migration is 
determined by their molecular weight. SDS is an anionic detergent that denatures proteins 
by wrapping around the polypeptide backbone and confers a negative charge to the 
polypeptide in proportion to its length.  
The cells were washed with ice-cold PBS, before addition of lysis buffer (Appendix 
1). The lysed cells were then scraped and the extracts were sonicated and left on ice for 30-
40min. The lysates were then centrifuged at 12000xg for 20 minutes at 4ºC and the 
supernatants recovered. The protein concentration was quantified using the BCA protein 
assay kit, and then the extracts were diluted with a 5x concentrated denaturing buffer 
(Appendix 1) and denaturated at 100ºC for 10min.  
Denatured extracts were resolved on SDS-PAGE (8-10% acrylamide) (Appendix1) 
and then electrotransferred onto a Polyvinylidene Difluoride (PVDF) membrane, overnight 
at 40V. 60µg of protein were loaded into the gels. Membranes were blocked for 1h in Tris-
buffered saline with 0.1% Tween20 (TBS-T) and 5% non-fat dry milk (Appendix 1) and 
then incubated for 1h at room temperature, or overnight at 4°C, with the primary antibody 
(anti-ubiquitin 1:2500) in TBS-T containing 1% milk. Membranes were then washed and 
incubated with alkaline phosphatase conjugated IgG secondary antibody (according to the 
primary antibody host specificity; anti-rabbit 1:10000) in TBS-T with 0.5% milk for 1h. 
After additional washes, the membranes were developed using enhanced 
chemifluorescence (ECF) substrate, and scanned using a Storm 860 Gel and Blot Imaging 
System (Amersham Biosciences, Buckinghamshire, UK). The intensity of the bands on the 
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membrane was analyzed with ImageQuant 5.0 software. For multiple probing, membranes 
were stripped of antibodies with NaOH 0.2M for approximately 20min, at room 
temperature, with gentle shaking, and then blocked with TBS-T with 5% non-fat dry milk 
and reprobed with primary (anti-actin 1:5000) and secondary (anti-mouse 1:10000) 
antibodies.  
 
2.2.8 RNA extraction  
 
 To perform microarrays, RNA extraction was carried out using Trizol reagent.  
Cells were washed twice with PBS and then 1mL of Trizol was added to each well 
of 6 multiwell plates. Samples were incubated for 5 min at room temperature to permit the 
complete dissociation of nucleoprotein complexes. Cells were scrapped and the content of 
each well was transferred to an eppendorf RNase free tube. 200 µL of chloroform 
(200µL/mL Trizol) was added to each eppendorf which were vigorously shaken by hand 
for 15 seconds and incubated for 2 to 3 min at room temperature. Samples were 
centrifuged at 12000 g for 15 min at 4ºC. The supernatants were then transferred to new 
eppendorf tubes and 500 µL of isopropanol (0.5 mL isopropanol/mL Trizol) was added to 
each eppendorf. Samples were centrifuged at 12000 g for 10 min at 4ºC. The supernatants 
were discarded and the RNA pellets were washed with 1 mL of ethanol 75% (1 mL 
ethanol/mL Trizol).  Samples were centrifuged 12000 g for 5 min at 4ºC. The supernatant 
was discarded and the pellet was resuspended in 10 µL of H2O miliQ (DEPC). Eppendorfs 
were incubated at 60ºC for 10 min.  
 
2.2.9 Oligonucleotide Microarrays  
 
A microarray is a special array of oligonucleotide probes, closely arranged in a 
small solid support surface, the slide. Oligonucleotide probes are arranged in spots and 
each spot corresponds to a specific gene. The position and nucleotide sequence of each 
probe are known. These arrays allow the simultaneous examination of the expression of 
thousands of genes.  
RNA sample preparation, hybridization, microarray wash, scaning and feature 
extraction were carried out using the protocol “One-Color Microarray-Based Gene 
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Expression Analysis – Low Input Quick Amp Labeling” version 6.5 from Agilent 
Technologies. In this protocol Cyanine 3-labeled targets were used to measure gene 
expression in experimental and control samples. No alterations were made to the original 
protocol. 
Raw data were normalized using BRB- Array Tools (Simon, Korn et al. 2003a). 
One-way ANOVA (p-value 0.01) was performed using MeV software (Saeed, Bhagabati et 
al. 2006). M values (log2 Ratios) were calculated using control samples as a reference. 
Functional analysis of expression data was carried out using DAVID Bioinformatics 
Resources 6.7, an online database (Huang, Sherman et al. 2008; Huang, Sherman et al. 
2009).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15. Schematic of amplified cRNA procedure (adapted from the protocol: “One-
Color Microarray-Based Gene Expression Analysis – Low Input Quick Amp Labeling” version 
6.5 from Agilent Technologies). From mRNA is produced cDNA using T7 promoter primer. 
From cDNA, cRNA attached to cyanine 3 (fluorescent dye) is produced. After purification 
cRNA will be hybridized in the oligo microarray.  
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2.2.10 Statistical analysis  
 
Results are presented as means+SD of the number of experiments indicated. 
Statistical significance for the results of cellular viability assay (MTT) and proteasome 
activity assay was assessed by one-way ANOVA analysis followed by the Dunnett’s test, 
using the software package GraphPad Prism 4. Statistical significance of the results of 
fluorescence microscopy was assessed by one-way ANOVA analysis followed by the 
Kruskal-Wallis test, using GraphPad Prism 4. Statistical significance of the results of flow 
cytometry was assessed by two-way ANOVA analysis followed by the Bonferroni test, 
also using GraphPad Prism 4.  
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Chapter III – Results  
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3.1 Effect of mistranslation on cellular viability and proliferation 
 
3.1.1 Cellular viability and proliferation – MTT results  
 
The MTT assay allows a rapid evaluation of the metabolic activity of viable cells 
and in toxicity studies using cell lines the changes in the reduction of MTT may arise from 
alterations in the rate of cell proliferation and/or effects on cell viability. 
To first assess the effect of the amino acid analogues, AZC and canavanine on cell 
viability/proliferation, the MTT assay was performed after exposure of the cells to the 
amino acid analogues for 48h.  The formazan product of this assay was quantified by 
spectrophotometry in an ELISA plate reader, as described in methods. The mean of 
absorbance values for each condition was calculated as well as the percentage of MTT 
reduction relative to the control (cells without addition of amino acid analogues). AZC and 
canavanine were tested at the following concentrations: 500µM; 1mM; 1.25mM; 1.5mM; 
2mM and 2.5mM (Figure 16).  
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 B 
 
 
Figure 16. Effect of AZC (A) and canavanine (B) on cellular viability/proliferation. Percentage of MTT 
reduction for each condition is relative to the control. Values represent mean+SD of triplicates. Statistical 
analyses were performed using one-way ANOVA and Dunnett´s post test (* represents p<0.05, *** 
represents p<0.001).  
 
 
 
Both drugs decreased MTT reduction in a dose-dependent manner when compared 
to the control cells which were not exposed to the amino acid analogues. 
At a concentration of 500µM none of the amino acid analogues affected 
significantly the percentage of MTT reduction (p<0.05), however, when tested at higher 
concentrations, AZC and canavanine decreased significantly the percentage of MTT 
reduction (* p<0.05 and *** p<0.001). Results with AZC treatment were similar to those 
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of the canavanine treatment and may be attributed to a decrease in the rate of cell 
proliferation or a reduction in overall cell viability.  
 
3.1.2 Cellular viability and proliferation assessed by nuclei counting and flow 
cytometry  
 
Nuclei of viable and non-viable cells were stained with the fluorescent dye Hoechst 
33342 and counted to distinguish if cells were dying, or if drugs were having an effect in 
cellular proliferation, instead of inducing cell death. Two concentrations of the amino acid 
analogues were tested, namely 1.5mM and 2.5mM. Cells were exposed to these 
concentrations for 48h except control cells which were not exposed to the amino acid 
analogues.   
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Figure 17. Effect of AZC (A) and canavanine (B) on cell viability. Nuclear morphology was analyzed 
by fluorescence microscopy after staining with Hoechst 33342 and the percentage of viable and apoptotic 
cells was then calculated. Values represent mean+SD of triplicates. Statistical analyses were performed using 
one-way ANOVA and Kruskal-Wallis post test (values were not statistically significant, p>0.05).  
CRT – control.  
 
 
 
At the concentrations tested, AZC and canavanine showed very low toxicity. These 
amino acid analogues had a low effect inducing cell death by apoptosis (Figure 17). The 
percentage of viable cells decreased, with the increase in concentration of AZC (Control – 
98,91%; 1.5mM – 96,56%; 2.5mM – 93,70%) and canavanine (Control – 98,84%; 1.5mM 
– 98,18%; 2.5mM – 96,26%). However, this difference was very small and not significant 
(p<0.05).  In the same way, the percentage of apoptotic cells increased with AZC (Control 
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– 1,09%; 1.5mM – 3,44%; 2.5mM – 6,3%) and canavanine (Control – 1,16%; 1.5mM – 
1,82%; 2.5mM – 3,74%), but not significantly (p<0.05).   
Flow cytometry analysis with propidium iodide confirmed these results (Figure 18). 
Again, cells were exposed for 48h to 1.5mM and 2.5mM of the amino acid analogues. 
AZC and canavanine induced cell death but at a low level for the concentrations tested. 
The percentage of apoptotic cells assessed by flow cytometry were similar to the results 
obtained by nucleus cell counting. Percentage of apoptotic cells increased with increasing 
concentrations of the amino acid analogue (AZC Control – 4,4%; AZC 1.5mM – 6.69%; 
AZC 2.5mM – 7,01%; canavanine Control – 2,19%; canavanine 1.5mM – 6,63%; 
canavanine 2.5mM – 9,42%).  
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Figure 18. AZC (A) and canavanine (B) toxicity in HEK293FT cells, as determined by flow cytometry 
in nuclei stained with propidium iodide. Values represent one independent experiment, one replicate. 
 
 
 
3.1.3 Cell cycle analysis by flow cytometry 
 
In order to evaluate the effect of mistranslation on cell cycle progression, 
propidium iodide was also used to stain cells for further flow cytometry analysis. 
HEK293FT cells were also incubated for 48h with AZC or canavanine at 1.5mM and 
2.5mM (Figure 19). 
54 
 
A 
 
B 
 
 
Figure 19. Effect of AZC (A) and canavanine (B) on HEK293FT cell cycle progression. Cell cycle 
analysis was conducted by flow cytometry with propidium iodide. After data acquisition percentage of cells 
in each phase of the cell cycle was calculated using ModFitLTTM v2.0 software. Values represent mean+SD 
of four independent experiments. Statistical analyses were performed using two-way ANOVA and 
Bonferroni post test (* represents p<0.05, ** represents p<0.01, *** represents p<0.001).  
 
  
The percentage of cells in phase G0-G1 decreased with the increase in the 
concentration of amino acid analogues. This difference was more proeminent in cells 
exposed to canavanine than AZC, where it was statistically significant. In contrats the 
percentage of cells in phase G2-M increased with increasing concentration of AZC and 
canavanine being this result statistically significant for canavanine. This can indicate that 
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cells are being arrested in phase G2-M. The observed changes in the percentage of cells in 
phase S, were different in HEK293FT cells incubated with AZC or canavanine. AZC 
decreased the percentage of S-phase cells (1.5mM), but increased it in presence of 2.5mM 
of AZC. Increased concentrations of canavanine increased the percentage of S-phase cells 
(statistically significant at p<0.01).  
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3.2 Protein quality control mechanisms activated in response to 
accumulation of misfolded proteins  
 
3.2.1 Detection of proteins conjugated with ubiquitin by western blot analysis 
 
Misfolded proteins are targeted, by the addition of ubiquitin chains to degradation 
by the proteasome system. In order to determine whether mistranslation induced formation 
of ubiquitinated proteins western blot analysis were carried out. Protein extracts from 
control cells and cells exposed for 48h to 1.5mM and 2.5mM of amino acid analogues 
were resolved by SDS-PAGE and then electrotransferred onto a PVDF membrane. 
Ubiquitin conjugates were detected using an anti-ubiquitin antibody.  
 
 
 
 
 
 
 
Figure 20. Effect of incubation of AZC and canavanine on protein ubiquitination. HEK293FT cells were 
treated with the drugs for 48h and anti-ubiquitin conjugates were detected with an anti-ubiquitin antibody. 
Samples 1 and 2 – Controls; 3 – AZC 1.5mM; 4 – AZC 2.5mM; 5 – canavanine 1.5mM; 6 – canavanine 
2.5mM. SDS-PAGE (8-10% acrylamide).60µg of protein were loaded for each sample. Results of one 
independent experiment.  
 
  
 
 The results showed an increase in ubiquitinated proteins, particularly in the 
presence of 2.5mM AZC, where the antibody staining was stronger. Canavanine (2.5mM) 
also increased antibody staining of proteins, but to a less extent than AZC. Low 
anti-Actin  
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concentrations of AZC and canavanine (1.5mM) did not significantly changed the antibody 
staining relative to the control cells extracts (Figure 20). 
 
3.2.2 Proteasome activity   
 
In order to elucidate whether the amino acid analogues altered proteasome activity, 
the activity of the latter was determined using a proteasome activity assay. Concentrations 
of amino acid analogues and time of exposure were those used to detect the ubiquitin 
conjugates by western blot analysis (see above).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 A 
 
B 
Figure 21. Effect of AZC (A) and c
Proteasome activity is expressed in the experimental conditions as a percentage of control (100%). Values 
represent mean+SD of four independent experiments. Statistical analyses were 
ANOVA and Dunne
 Amino acid analogues at these concentrat
significantly the activity of 
the ubiquitinated proteins is not due to a down
proteasome. AZC increased proteasome activity 
(2.5mM), but this small incr
canavanine where proteasome activity increased
(2.5mM), but again this increase was
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anavanine (B) on proteasome activity in HEK293FT cells
performed using one
tt´s post test (values were not significant, p<0.05).
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the proteasome (Figure 21), indicating that the accumulation of 
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3.3 Transcriptional responses to mistranslation  
 
In order to unveil the molecular meachanisms that are activated in response to 
mistranslation, oligo microarrays were performed. Once again we exposed HEK293FT 
cells to the amino acid analogues AZC and canavanine for 48h, using two concentrations 
1.5mM and 2.5mM. Control cells were not exposed to the amino acid analogues. Total 
RNA was extracted from three independent cultures. After purification and labeling with 
Cy3, cRNA was hibridyzed on an Agilent Microarray as described in methods.  
After extraction using Agilent Feature Extraction Software, the data was 
normalized using BRB Array Tools. In order to identify genes whose expression changed 
significantly in presence of the amino acid analogues, One-way ANOVA (p-value 0.01) 
was carried out using the MeV software package. Genes which expression was 
significantly different (p-value 0.01) were clustered in up-regulated (from control to 
1.5mM and 2.5mM) and down-regulated genes (from control to 1.5mM and 2.5mM) for 
both amino acid analogues, using Expander 5 sofware. Genes that did not show the same 
pattern in both concentrations, for example were up-regulated from control to 1.5mM and 
down-regulated from 1.5mM to 2.5mM, in spite of having a significantly different 
expression pattern were not considered for the analysis.   
  
 
Figure 22. Number of genes up and down-regulated with the amino acid analogues AZC and 
canavanine.  
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Addition of AZC to cells altered expression of 447 genes, 132 of them were up-
regulated and 315 were down-regulated, while canavanine deregulated 785 genes, 399 
were up-regulated and 386 were down-regulated (Figure 22).  
 
 
3.3.1 Functional analysis of down-regulated genes 
 
Genes were grouped in: AZC up-regulated genes, AZC down-regulated genes, 
canavanine up-regulated genes and canavanine down-regulated genes. Functional analyses 
of each one of these groups was carried out using the online database DAVID 
Bioinformatics Resources 6.7. 
 
 
Table 1. Functional categories of the genes down-regulated by AZC.  
 
Gene Ontology Annotation  p-value (Modified Fisher Exact p-value, EASE score)  
Extracellular matrix part 1.1x10-3 
Proteinaceous extracellular matrix 1.3x10-3 
Laminin complex 3.4x10-3 
Basal lamina  1.2x10-2 
Growth factor binding  1.2x10-2 
Nucleotidyltransferase activity  2.2x10-2 
Basement membrane  4.3x10-2 
Response to oxygen levels  4.3x10-2 
Collagen  4.7x10-2 
DNA polymerase activity  5.0x10-2 
Cell projection organization  5.6x10-2 
Oxidation reduction 7.5x10-2 
Cell morphogenesis involved in 
differentiation  7.8x10
-2 
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The incorporation of AZC into proteins decreased the transcription of genes 
encoding proteins of the extracellular matrix and mainly involved in cell-adhesion (Table 
1). For example COLGA1 and COL13A1 codify two types of collagen, an important 
molecule in cell attachment, migration and organization of cells into tissues. The 
EGFLAM gene encodes a protein involved in matrix assembly and cell adhesiveness and is 
also in this group. Proteinaceous extracellular matrix proteins include proteins which are 
important for interaction between cells and between cells and extracellular matrix. An 
important gene in this process is the KAZALD1 which leads to matrix assembly. Genes 
that codify laminins, namely LAMA1, LAMA5, LAMC2, which are components of the 
basal lamina were also down-regulated.  Another category of down-regulated genes is 
involved in response to oxygen levels. Surprisingly, some genes whose proteins are 
important to counteract the negative effects of ROS and promote inhibition of growth and 
cell death were down-regulated, namely DDIT4 and CDKN1A.  
Some down-regulated genes were not annotated in any category, namely genes that 
code for several transmembrane proteins, and some members of the MAP kinase family.  
Similar results were obtained with canavanine (Table 2). Genes involved in the 
maintenance of the extracellular matrix (Extracellular region part; Extracellular matrix 
structural constituent and Proteinaceous extracellular matrix; Extracellular matrix 
organization) were down-regulated, for example, genes that codify collagen (COL5A2, 
COL13A1, COL2OA1), laminin (LAMC2) and cell adhesion proteins (SPON2). Similarly 
to AZC, some genes that were down-regulated with canavanine are involved in the 
response to oxygen levels, namely the gene DDIT4, which is down-regulated in cells 
exposed to AZC. Genes that were not clustered in any GO term were involved in 
transcription, for example TCEA2 (transcription factor).  
 
 
 
 
 
 
 
 
  
Table 2. Functional c
 
GO Annotation 
Extracellular region part 
Extracellular matrix structural 
constituent 
Proteinaceous extracellular matrix
Collagen  
Nucleotidyltransferase activity 
Glycoprotein metabolic process 
Nucleobase, nucleoside, nucleotide 
and nucleic acid catabolic process  
Extracellular matrix organization 
Response to oxygen levels 
 
Some genes are down
group of genes can provide new insights into the 
mistranslation because AZC and c
aggregation, despite their different chemical properties. 
69 of the down-regulated
canavanine (Figure 23). The list of these
Appendix 2.  
                                    
 
 
 
 
 
 
 
 
 
 
 
Figure 23. Genes down-regulated only with AZC, only with Canavanine and 
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ategories of the genes down-regulated by canavanine.
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Functional analysis of the 69 down-regulated genes, were performed using DAVID 
Bioinformatics Resources 6.7. GO annotation tool showed enrichment of genes that were 
mainly Membrane components (p-value=2.3x10-2). Some of the genes annotated in this 
category are referred in the Table 3.  
 
Table 3. Examples of genes that were annotated in the GO category Membrane components. 
 
Genes Proteins encoded  
SLITRK6 
RPRML 
TMEM80 
TMEM129 
TMEM107 
PRRT2 
SECTM1 
STRA6 
Transmembrane proteins 
ANO7 Protein involved in cell-cell interactions  
COL13A1 
DHRS11 
Proteins related to cell matrix and cell adhesion  
FIBP Protein involved in tissue growth and differentiation  
FUT11 Protein associated with protein modification  
PIGL Protein responsible for glycolipid biosynthesis  
 
 Many of the down-regulated genes annotated in the cluster Membrane components 
codify transmembrane proteins. There are also genes that codify proteins involved in cell-
cell interactions and cell matrix and cell adhesion, for instance collagen (COL13A1) and a 
secreted oxireductase (DRHS11). Cells exposed to amino acid analogues also down-
regulated a gene responsible for mitogenesis and cell differentiation (FIBP). These genes 
(COL13A1, DRHS11 and FIBP) show similar fold changes in cells treated with AZC and 
with canavanine (Appendix 2). 
 From the 69 down-regulated genes, some of them were not annotated in any 
functional group. Table 4 shows these down-regulated genes. 
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Table 4. Examples of genes that were not annotated in any GO category but are also down-regulated 
with AZC and canavanine. 
 
Genes Proteins encoded  
NES 
OBSL1 
PDLIM7 
CORO2A 
Proteins associated with cytoskeleton and intermediate filaments 
DDIT4 
BAD 
 Proteins responsible for inhibition of cell growth and stimulation of 
cell death  
TCOF1 
 Protein involved in ribosomal DNA gene transcription 
RAB26 
 Protein that regulate vesicular fusion and trafficking 
SLC25A15 
 Mitochondria membrane proteins 
PEX26 
ADLP 
 Peroxisome membrane proteins 
TTC39A 
 Protein that mediate protein-protein interactions  
PRODH 
 Protein involved in proline degradation  
 
 Again we can see that genes that codify many membrane proteins and organelles 
membrane were down-regulated. Genes that code for proteins associated with cytoskeleton 
and intermediate filaments, and regulate cellular trafficking were also down-regulated.  
 
3.3.2 Functional analysis of up-regulated genes   
 
Genes that were up-regulated by AZC are annotated mainly in the GO Terms: 
Transcription factor binding, Oxidation reduction and Response to unfolded proteins 
(Table 5).  
 
Table 5. Functional categories of the genes up-regulated by AZC. 
 
GO Annotation  p-value (Modified Fisher Exact p-value, EASE score)  
Transcription factor binding  8.1x10-3 
Oxidation reduction  1.5x10-2 
Response to unfolded protein  2.1x10-2 
Transcription  2.7x10-2 
Transcription from RNA polymerase 
II promoter 3.8x10
-2 
Response to protein stimulus  4.5x10-2 
RNA biosynthetic process  6.7x10-2 
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The first GO category Transcription factor binding includes genes that codify 
transcription regulators and components of transcription factors. One example is the MAX 
gene that codifies a transcription regulator that may repress transcription via the 
recruitment of a chromatin remodeling complex. Two important categories of up-regulated 
genes were Response to unfolded protein and Response to protein stimulus. These 
categories included DDIT3 which is a transcription factor that is mainly activated by ER 
stress and promotes apoptosis; DNAJB1 which interacts with Hsp70 and stimulate its 
ATPase activity and HSPH1which codifies a heat shock protein that prevents the 
aggregation of denatured proteins in cells under severe stress and belongs to the Hsp70 
family.  
Once again cellular response to AZC and canavanine were similar (Table 6). For 
example, Regulation of transcription and Regulation of RNA metabolic processes were up-
regulated in both cases. Regulation of transcription is mainly negative, and these categories 
include many transcription factors and components of transcription factors, namely zinc 
finger proteins. Some genes belong to the category Positive regulation of cell death, 
namely SAP30BP and CIDEC, which codify proteins that induce cell death by apoptosis. 
One gene which was not annotated in any category is AHSA1which codes for an activator 
of the Hsp90.   
    
Table 6. Functional categories of the genes up-regulated by canavanine.  
 
GO Annotation  p-value (Modified Fisher Exact p-value, EASE score)  
Regulation of transcription, DNA-
dependent  1.3x10
-6
 
Regulation of RNA metabolic process 2.4x10-6 
Regulation of transcription  1.9x10-5 
Negative regulation of gene 
expression  5.5x10
-4
 
Negative regulation of cellular 
biosynthetic process  1.6x10
-3 
Transcription from RNA polymerase 
II promoter 3.3x10
-3 
Positive regulation of cell death  2.5x10-2 
 
 20 genes up-regulated in cells exposed to AZC 
exposed to canavanine (Figure 24
 
                              
 
 
 
 
 
 
 
Figure 24. Genes up-regulated only with AZC, only with Canavanine and with both amino acid analogues.
 
 
Because of the low number of genes 
canavanine, variable genes did not show enrichment for 
(Table 7).  
Table 7. Examples of genes that were up
Genes  
AFG3L1P 
BBS12 
SETD4 
HOXA4 
ZNF320 
CD81 
GUSBP1 
SRGAP2 
SMPD3 
 
 The list of the 20 up
these genes are related with the stress response to 
be involved in protein quality control. AFG3L1P codifies an ATP
metalloprotease, which seems to be involved in
assembled mitochondrial inner membrane proteins and can also function as a chaperone 
mediating the assembly of membrane
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112 379
were also up
). 
AZC          Canavanine 
that were up-regulated 
any particular functional group 
 
-regulated by both AZC and c
Proteins encoded  
Proteins involved in protein quality control
Proteins involved in transcription process and 
regulation  
Cell surface protein 
Beta-glucuronidase  
Protein involved in membrane protrusion  
Proteins involved in cell stress response 
-regulated genes can be found in the Appendix 3
accumulation of unfolded protein
 protein quality control, degrades non
-associated ATP-synthetase. The protein encoded by 
20 
-regulated in cells 
 
by both AZC and 
anavanine 
 
. Some of 
s, and 
-dependent zinc 
-
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BBS12 is a molecular chaperone that aids in protein folding upon ATP hydrolysis, and 
interacts with two other chaperonin-like BBS proteins, namely MKKS/BBS6 and BBS10 
to form a chaperonin complex. Some genes are related to transcription process, such as 
SETD4, that probably functions by methylating histones on lysine residue, HOXA4 which 
codifies a DNA-binding transcription factor that may regulate gene expression, 
morphogenesis and differentiation and finally ZNF320, a gene that codifies the zinc finger 
protein 320. AZC and canavanine lead also to the up-regulation of SMPD3.  This gene 
codifies a phosphodiesterase that hydrolyzes sphingomyelin to phosphocholine and 
ceramide. Ceramide is important in the coordination of eukaryotic stress responses and 
directs cells to the execution of specific programs of cell cycle arrest, differentiation and 
apoptosis.  
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Chapter IV – Discussion, 
Conclusions and Future 
Perspectives 
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4.1 Overview 
 
The mRNA mistranslation phenomenon has been attracting increasing attention 
during the last few years. New discoveries associate mistranslation to generation of 
phenotypic diversity and evolution of the genetic code in some organisms, such as Candida 
albicans. New proteins formed can have advantageous functions, for example can allow 
the survival in toxic environments, creating a selective advantage (Miranda, Rocha et al. 
2007; Moura, Paredes et al. 2010). But, mistranslation is also frequently associated to 
many diseases, in mice and humans (Nangle, Motta et al. 2006; Drummond and Wilke 
2008; Schimmel 2008). Amino acid misincorporation into protein, due to loss of 
translational fidelity results in the formation of aberrant proteins whose accumulation 
usually leads to the formation of protein aggregates that are extremely toxic to cells and 
can lead to apoptosis (Schimmel 2008). The connection of mistranslation and human 
diseases makes this, an interesting subject in many scientific fields, for example, in 
biomedicine and in the pharmaceutical industry. Some of the toxicity mechanisms of 
misfolded proteins and protein aggregates have been elucidated in the past few years, but a 
comprehensive study of the magnitude of morphological cell alterations and cell stress 
response is essential to understand the effects of mistranslation and its connections with 
diseases.  
To understand how human cells cope with error accumulation during protein 
synthesis, an in vitro model of mistranslation was used here. AZC and canavanine two 
amino acid analogues were used to induce mistranslation in human HEK293FT cells. 
These amino acid analogues are misincorporated into proteins instead of the natural amino 
acids and lead to the formation of misfolded proteins (Rodgers and Shiozawa 2008). With 
the objective of testing the level of toxicity caused by incorporation of these amino acid 
analogues a cellular viability assay was performed (MTT). Cells were also observed using 
light microscopy and analyzed by flow cytometry to detect the number of apoptotic cells 
for each drug concentration used. These analyses were important to determine levels of 
mistranslation that did not cause high level of cell death, which would introduce noise in 
our study of the cellular responses to the accumulation of misfolded proteins. 
Studies with HEK cells expressing aggregation-prone proteins, such as huntingtin, 
have shown that protein aggregation leads to cell cycle arrest primarily at the G2-M 
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boundary (Bence, Sampat et al. 2001). Cell cycle analyses were also carried out in this 
study to verify if this low level of mistranslation could lead to cell cycle arrest.  
Human cells possess a variety of protein quality control mechanisms to minimize 
the accumulation of aberrant proteins and their toxic effects. Molecular chaperones are one 
of them (Bukau, Weissman et al. 2006). Chaperones are crucial for maintaining the native 
protein conformation and preventing nonspecific aggregation (Zhang, Beuron et al. 2002). 
When cells detect accumulation of misfolded proteins, they elevate the expression of 
molecular chaperones. The primary form of regulation is at the level of transcription 
(Morimoto 2008 ).  
Another mechanism of protein quality control is the ubiquitin-proteasome system 
that degrades proteins by proteolysis. Misfolded proteins are in general polyubiquitinated 
prior to degradation by the 26S proteasome (Dahlmann 2007). Our data showed that 
proteins were conjugated with ubiquitin in cells exposed to AZC and canavanine.  
Additionally, protein aggregation impair the function of the ubiquitin-proteasome 
system, which could lead to cellular deregulation and cell death (Bence, Sampat et al. 
2001). In our cells proteasome activity did not change significantly suggesting that the 
aberrant proteins may accumulate instead of being degraded.  
Finally, microarray analyses of the transcriptome showed that AZC and canavanine 
misincorporation deregulate gene expression, and highlighted the major protein functional 
categories affected. 
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4.2 Mistranslation has a negative impact on cellular viability and cell 
proliferation  
 
It is well known that proteins with abnormal conformations can originate 
aggregates, which disrupt homeostasis and can lead to cell death. Especially in neurons, 
where protein aggregates have a strong negative impact in viability, as toxic aggregates 
and cannot be diluted by cell division. For this reason diseases associated to accumulation 
of misfolded proteins are mainly neurodegenerative disorders (Lee, Beebe et al. 2006 ). 
Cell death can be a consequence of the toxic effects of aberrant proteins, but can also be 
due to loss of function of essential proteins (Rochet 2006).  
The MTT assay was used in our study to understand the effect of the amino acid 
analogues in cell viability and proliferation. This assay measures the metabolic activity of 
viable cells. Since proliferating cells are metabolically more active than non-proliferating 
cells, the assay is suitable not only for the determination of cell viability, but also for the 
determination of cell activation and proliferation (Wyllie 2009). Results showed a decrease 
in MTT reduction with increasing concentrations of the amino acid analogues, suggesting a 
negative impact of mistranslation in cellular viability and proliferation. In order to 
distinguish if this negative effect was related to an increase in cell death or decreased 
proliferation, nuclei were counted and flow cytometry analysis were carried out.  
Nuclei stained with Hochest 33342 can be visualized by light microscopy which 
also allows differentiating death from viable cells. Our data showed that the percentage of 
apoptotic cells increased slightly only with increasing concentrations of AZC and 
canavanine. These results were confirmed by flow cytometry analysis with propidium 
iodide. Therefore, the range of concentrations of the amino acid analogues used in this 
work are likely to induce a low level of mistranslation and allow studing cellular responses 
to this phenomenon. Under these experimental conditions the low level of apoptotic cell 
death in HEK293FT cells may be due to the activation of PQC mechanisms which allow 
the cells to cope with the level of aberrant proteins formed.  
Cell cycle analysis by flow cytometry of cells stained with propidium iodide 
showed decreased number of cells in G0-G1 phase, and increased number of cells in G2-M 
phase. AZC at 1.5mM decreased the number of cells in the S phase, but increased it at 
2.5mM. Canavanine increased the percentage of cells in the S phase with increasing drug 
concentration.  
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Previous studies showed that canavanine is able to arrest cell cycle progression of 
human lung adenocarcinoma A549 cells in the G1 phase by inducing up-regulation of the 
negative cell cycle regulators p53 and p21WAF1 (Ding, Matsukawa et al. 1999).  
Furthermore, Jurkat T cell cultures exposed to similar concentrations of canavanine (this 
amino acid analogue possess cytotoxicity to tumor cells), show higher percentage of cells 
in the S and G2-M phases before a remarkable increase in sub-G1 apoptotic cells. 
Apparently, 1.25mM and 2.5mM canavanine interrupts the completion of the S and M 
phase of Jurkat T cells. Some authors postulated that the effects of canavanine on the cell 
cycle may vary between cell types (Jang, Jun et al. 2002 ). The cell culture conditions, 
namely nutrients and gases availability can also fluctuate and may influence the state of 
proliferation of cells changing slightly the results between cell types, and even between 
cell replicates. Our results support those data. Canavanine at concentrations of 1.5mM and 
2.5mM decreased the percentage of cells in G0-G1 and increased the percentage of cells in 
G2-M and S, suggesting that cell cycle progression to the S phase may be compromised 
and S phase completion may be interrupted.  
Previous studies also refer the anti-tumor effects of AZC in vitro and showed a 
preferentially cell cycle arrest at the G2-M phase (Komander, Clague et al. 2009).  
The only mechanism of toxicity reported so far to cause these effects in cell 
cultures involve the misincorporation of AZC and canavanine into proteins which may 
disrupt critical proteins required for the progression of the cell cycle. Apoptotic cell death 
increases slightly in the presence of these amino acid analogues and cells seem to arrest the 
progression of the cell cycle and be prevented from completing the phase S of DNA 
replication.  
  
74 
 
 
4.3 Mechanisms of Protein quality control in HEK293FT Cells  
 
A brief revision of the primary responses to misfolded proteins is illustrated in 
Figure 25. Misfolded proteins that accumulate in cells can be refolded by molecular 
chaperones, degraded by UPS-mediated proteolysis, aggregate in the cytoplasm or in the 
nucleus or be secreted to the extracellular space (Ciechanover and Brundin 2003). In this 
study we aimed at testing whether misfolded proteins are targeted for degradation or 
whether the proteasome activity is compromised.  
 
 
 
Figure 25.  Primary responses to the accumulating of misfolded proteins. Misfolded proteins  may be 
refolded by chaperones, may be targeted from degradation and may accumulate in aggregates in cytoplasm, 
nucleus or extracellular space, and sequester additional proteins [adapted from (Papa and Hochstrasser 1993)] 
 
 
The accumulation of misfolded proteins triggered a stress response in HEK293FT 
cells. SDS-PAGE showed that AZC and canavanine increased ubiquitin conjugated 
proteins. These results are concordant with the study of Dasuri and colleagues who 
exposed neuronal and astrocyte cell cultures to AZC and canavanine and showed time-
dependent increase of ubiquitinated proteins (Dasuri, Ebenezer et al. 2011).  
It was reported that proteasome activity may be altered (increase or decrease) by 
accumulation of misfolded proteins. Parsell and Lindquist have shown that it is likely that 
an increase in damaged and misfolded proteins following heat shock up-regulate 
proteasome activity (Canu, Barbato et al. 2000). Consistent with this hypothesis, other 
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studies have demonstrated that proteasome activity can be rapidly elevated in response to 
mild oxidative stress (Reinheckel, Ullrich et al. 2000). This increase in proteasome activity 
seems to be due to accumulation of misfolded proteins up to a certain level. When the 
capacity of the proteasome to degrade proteins is overwhelmed, with rates of 
formation/delivery of misfolded proteins exceeding the capacity of the UPS to target and 
proteolytically degrade them, misfolded proteins can cause proteasomal stress and inhibit 
its activity (Papa and Hochstrasser 1993).  
A number of studies refer UPS dysfunction in neurodegenerative disorders, such as 
Parkinson’s and Alzheimer’s diseases, caused by accumulation of aggregation-prone 
proteins (Papa and Hochstrasser 1993; Keller, Hanni et al. 2000). It was also demonstrated 
that soluble aggregated proteins inhibit the ubiquitin system (Bence, Sampat et al. 2001). 
In this study, Bence and colegues demonstrated in a cell cultured model that 
overexpression of mutant Huntingtin lead to proteasome inhibition. Another study showed 
that UPS inhibition only occurs under conditions of increased stress in cells expressing 
mutant Huntingtin (Amerik, Swaminathan et al. 1997). This increased proteotoxic stress is 
due to an elevated number of protein aggregates.  
Our data indicates that AZC and canavanine do not alter proteasome activity likely 
because misfolded proteins are being efficiently targeted and degraded by the UPS and do 
not lead to proteasome stress. In other words, misincorporation of those amino acid 
analogues was not sufficient to alter proteasome activity. Higher concentrations of amino 
acid analogues may be required to alter proteasome activity. Possibly the cell type model 
can also influence the results, but this issue needs to be further investigated.  
Since under the experimental conditions used in this work the accumulation of 
polyubiquitinated proteins was not a consequence of UPS impairment, they may 
accumulate despite the presence of a largely functional UPS. For example, if ubiquitinated 
substrates are sequestered into larger protein aggregates before reaching proteasome, this 
could explain the increase in ubiquitin conjugates observed in the SDS-PAGE. 
Ubiquitination can be involved in other processes such as clearance of aggregated proteins 
by macroautophagy which is a protective response that defends cells against the toxic 
insults of aggregation-prone proteins (Maynard, Böttcher et al. 2009). Deubiquitinating 
enzymes (DUBs) catalyze the removal of ubiquitin from proteins thus playing an important 
role in the editing of ubiquitination state of proteins and in the recycling of ubiquitin. Also 
these DUBs need to undergo structural rearrangements to adopt an active conformation 
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(Komander, Clague et al. 2009). If AZC and canavanine are being misincorporated in 
DUBs this can lead to inhibition of deubiquitination and consequently the increase in 
ubiquitinated proteins in cells. In yeast, disruption of DUBs leads to accumulation of 
polyubiquitn proteins and to depletion of cellular ubiquitin pools (Papa and Hochstrasser 
1993; Amerik, Swaminathan et al. 1997; Canu, Barbato et al. 2000).  
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4.4 Gene transcription alterations  
 
Many studies have reported several mechanisms that are activated in response to 
mistranslation and proteotoxic stress. However, a global view of the transcriptional 
mechanisms that are activated to counteract mistranslation in mammalian cells is still 
missing.  
 In Saccharomyces cerevisiae sub-lethal concentrations of AZC induced expression 
of heat-shock factor-regulated genes and selectively repressed the expression of ribosomal 
protein genes. Treatment with canavanine was less potent than with AZC and did not 
activated heat-shock factor (Trotter, Kao et al. 2002 ). 
Human cells communicate with each other to respond to physiological stimulus and 
the diversity of human cell types may be accompanied by a corresponding diversity in their 
response to stress. Also, these cells have many physiological behaviors that contribute to 
their stress response, such as apoptosis and complex intercellular interactions, that are not 
present in yeast (Murray, Whitfield et al. 2004 ).  
The HEK293FT cells exposed to amino acid analogues down-regulate genes mainly 
associated with the extracellular matrix which provides structural support to the cells and 
allows communication between them. Down-regulation of genes that codify proteins 
required for the maintenance of the extracellular matrix, namely collagen and laminins 
among others, transmembrane proteins and proteins involved in cell-cell interactions can 
compromise cell adhesion, and also communication. Additionally, cell morphology can be 
altered because of the down-regulation of several genes that codify proteins that maintain 
the cytoskeleton and intermediate filaments.  
It would be interesting to carry out a detailed analysis of cell morphology and 
organization in culture to evaluate whether those gene expression alterations result in 
altered morphology. Since the extracellular matrix and controlled cell adhesion are 
essential for a coordinated morphogenesis and growth during embryonic development and 
since HEK293FT cells are embryonic kidney cells, it is reasonable to assume that AZC and 
canavanine will alter their morphology (Kuschel, Steuer et al. 2006).  
Our microarray data also showed that genes involved in tissue growth and 
differentiation were down-regulated by AZC and canavanine suggesting that these 
processes are being compromised. The other main functional category down-regulated was 
the response to oxygen. This was a surprising result because it is known that accumulation 
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of misfolded proteins lead ER stress and consequently UPR activation which yields ROS 
accumulation (Haynes, Titus et al. 2004). In other words, we were expecting up-regulation 
of genes involved in oxygen metabolism.  
Functional class analysis of genes up-regulated by AZC identified Transcription 
factor binding and Transcription as the main categories affected. Many transcription 
regulators were up-regulated, especially those that repress transcription, for example 
MAX. This suggests that overall transcription may be repressed in order to avoid synthesis 
of proteins that could misfold and compromise cell viability. Canavanine also lead to up-
regulation of genes involved in Regulation of transcription and Negative regulation of gene 
expression. Additionally some genes up-regulated by canavanine participate in Positive 
regulation of cell death by apoptosis, which may indicate that misincorporation of 
canavanine does have a negative impact on viability. In viability assays we see an increase 
in the number of apoptotic cells, but this is very small, suggesting that this amino acid 
analogue, at these concentrations tested has low toxicity.  
AZC exposure up-regulated genes involved in Protein Quality Control, Response to 
unfolded protein and Response to protein stimulus, namely DDIT3, DNAJB1 and HSPH1 
which belong to the classic UPR pathway (Dombroski, Nayak et al. 2010). DDIT3 is a 
transcription factor that promotes apoptosis, DNAJB1 stimulates HSP70 ATPase activity 
and HSPH1is a heat shock protein that prevents aggregation of denatured proteins. The 
genes up-regulated by canavanine were not annotated in any of these functional classes, 
however the AHSA1, an activator of HSP90, which also belongs to the classic UPR 
pathway, was up-regulated (Dombroski, Nayak et al. 2010). Two genes, AFG3L1P and 
BBS12 that seem to be involved in protein quality control were also up-regulated by AZC 
and canavanine. AFG3L1P codifies a protein that can function as a chaperone and can 
degrade non-assembled mitochondrial inner membrane proteins, while BBS12 is a 
molecular chaperone. In spite of being involved in protein quality control these genes have 
not been reported to participate in UPR pathway.  
 Other up-regulated genes by AZC and canavanine are involved in transcription 
processes, negative transcription regulation and in cell stress response. For example, the 
SMPD3 gene which participates in the coordination of eukaryotic stress responses was 
identified in our data set. It is known that several stress agents, namely chemotherapeutic 
drugs and heat regulated sphingolipid metabolism by increasing the activity and 
concentration of enzymes that cause ceramide accumulation. Recent studies suggest that 
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ceramide is essential for mediating many of these stress responses. Ceramide can direct 
cells to cell cycle arrest, through retinoblastoma protein (Rb) activation  and apoptosis, 
through caspases activation (Hannun and Luberto 2000; Nikolova-Karakashian and 
A.Rozenova 2010).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
80 
 
4.5 Conclusions and Future Perspectives  
 
The objective of this study was to elucidate the cellular responses to mistranslation. 
For this, we have exposed human HEK293FT cells to the proline and arginine analogues, 
AZC and canavanine. The data demonstrate that cells counteract the negative effects of 
mistranslation by activating mechanisms that prevent progression of the cell cycle and the 
completion of the phase S. Apoptosis is also activated but to a lower extent.  
As expected, HEK293FT cells activate mechanisms of protein quality control to 
counteract protein misfolding and aggregation induced by AZC and canavanine. Proteins 
are targeted for degradation by the ubiquitin-proteasome system, but the activity of the 
proteasome was not altered by the accumulation of misfolded proteins, suggesting that the 
level of misfolded proteins and aggregates was low. Despite this UPR was activated. 
Indeed, genes that belong to this classical pathway, namely DDIT3, DNAJB1, HSPH1 and 
AHSA1 were up-regulated to neutralize the accumulation of misfolded proteins and avoid 
protein aggregation. Other genes that are involved in protein quality control were also up-
regulated, namely AFG3L1P and BBS12. We could complete this work assessing the 
levels of some of the heat shock proteins, for example Hsp70, Hsp40 and Hsp90 by 
western blot, because regulation of molecular chaperones can also be at translational level 
(Dasuri, Ebenezer et al. 2011).  
As mentioned before, an unexpected result was the down-regulation of genes 
involved in the response to oxygen levels. It would be interesting to assess if ROS 
accumulate in these cells. Indeed, a recent study using AZC and canavanine to generate 
abnormal proteins in aging cells and neurodegeneration showed increased oxidative stress 
in both neurons and astrocytes (Dasuri, Ebenezer et al. 2011).   
Our study shows therefore that mistranslation induced by amino acid analogues is a 
good model system to study the biology of protein misfolding and aggregation. It would be 
important to test additional drug concentrations and exposure time to obtain a more 
detailed understanding of the cellular responses to protein aggregation. It would also be 
interesting to evaluate protein aggregation in more detail using other techniques such as 
congo red or thioflavin staining. Finally, it would be exciting to create other models to 
induce controlled mistranslation in mammalian cells, for example by expressing 
misreading tRNAs.  These models of mistranslation have the potential to help elucidate the 
biology of protein aggregation diseases.  
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Appendix  
 
1. Solutions  
 
 
PBS  
 
• 137 mM NaCl 
• 2,7 mM KCl 
• 10 mM Na2HPO4 
• 1,8 mM KH2PO4 
 
• pH was adjusted to 7.4 
 
 
Lysis buffer for Proteasome activity detection  
 
• 1mM EDTA  
• 10 mM tris-HCl, pH 7.5 
• 20% glycerol 
• 4 mM DTT (dithiothreitol)  
• 2 mM ATP  
 
Proteasome Activity buffer  
 
• 0,5 mM EDTA  
• 50 mM Tris-HCl, pH 8  
• 2 mM ATP  
• 50 µM Suc-LLVY-MCA 
• 10 µM MG132 (just in one of the duplicates)  
 
Lysis buffer for Western Blot   
 
• 50mM HEPES 
• 150mM NaCl 
• 2mM EGTA 
• 1mM EDTA 
• 1mM DTT 
• 2mM Na3VO4 
• 50mM NaF 
• 1% Triton X-100 
 
• pH was adjusted to 7.4 
 
• supplemented with 1mM PMSF and 1µg/ml CLAP in the moment of lysis  
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Denaturating buffer for Western Blot    
 
• 0,25 mM Tris, pH 6,8 
• 4% SDS 
• 200 mM DTT  
• 20% glycerol 
• 0,01% bromophenol blue  
 
 
Running gel for Western Blot (10%)   
 
H2O 3,95 mL 
Tris 1,5 M, pH 8,8 3,35 mL 
40% Acrilamide (Acrilamide/Bisacrilamide 
solution, 37,5:1) 
2,5 mL 
20% SDS 100 µL  
10% AMPS (0,1g in 1mL H2O) 100 µL 
TEMED  5 µL 
 
Stacking gel for Western Blot (4%)  
 
H2O 3,1 mL 
Tris 0,625 M, pH 6,8 125 mL 
40% Acrilamide (Acrilamide/Bisacrilamide 
solution, 37,5:1) 
0,5 mL 
20% SDS 50 µL  
10% AMPS (0,1g in 1mL H2O) 50 µL 
TEMED  5 µL 
 
 
Electrophoresis buffer for Western Blot  
 
• 100 mM Tris 
• 100 mM Bicine 
• 0,1% SDS  
 
 
Electrotransfer buffer  
 
TBS 10x 
 
2 L 
200 mM Tris  24,2 g  
1,37 M NaCl 80,0 g  
 
• Adjust the pH to 7,6 
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TBS-T with 0,5% milk  
 
2 L 
TBS 10x 200 mL 
0,1% Tween  2 mL 
0,5% milk 10 g  
H2O mQ  To add up to 
2 L 
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2. List of genes down-regulated in cells exposed to AZC or to canavanine 
 
Gene name Gene symbol 
AZC 
Fold 
Change(*) 
Canavanine 
Fold  
Change(*) 
ADAM metallopeptidase with 
thrombospondin type 1 motif, 4  
 
ADAMTS4 0.78 0.50 
anoctamin 7 ANO7 0.71 0.45 
arachidonate 5-lipoxygenase 
 
ALOX5 0.59 0.33 
ArfGAP with GTPase domain, ankyrin 
repeat and PH domain 2 
AGAP2 0.72 0.60 
arrestin, beta 1 ARRB1 
 
0.81 0.56 
ATG16 autophagy related 16-like 2 ATG16L2 0.69 0.57 
ATP-binding cassette sub-family D 
member 1 (Adrenoleukodystrophy protein) 
ALDP 0.73 0.70 
Bcl2 antagonist of cell death BAD 0.71 0.73 
beta-1,4-N-acetyl-galactosaminyl 
transferase 1 
B4GALNT1 
 
0.56 0.21 
chemokine (C-C motif) receptor 10  CCR10 0.70 0.48 
chromosome 6 open reading frame 108 C6orf108 
 
0.77 0.76 
chromosome 6 open reading frame 126 C6orf126 0.67 0.45 
collagen, type XIII, alpha 1 COL13A1 0.65 0.56 
coronin, actin binding protein, 2A  CORO2A 0.85 0.70 
crystallin, mu  CRYM 0.72 0.48 
cyclin I family, member 2 CCNI2 
 
0.80 0.44 
DAN domain family, member 5 DAND5 0.65 0.361 
Dehydrogenase/reductase SDR family 
member 11 
 
DHRS11 0.70 0.76 
DNA-damage-inducible transcript 4 DDIT4 0.63 0.27 
ectonucleoside triphosphate 
diphosphohydrolase 8 
ENTPD8 0.80 0.48 
exocyst -like pseudogene LOC644145 0.65 0.36 
family with sequence similarity 27, 
member A 
FAM27A 0.79 0.45 
fibroblast growth factor (acidic) 
intracellular binding protein 
FIBP 
 
0.73 0.71 
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fucosyltransferase 11 (alpha (1,3) 
fucosyltransferase) 
FUT11 0.82 0.42 
GNAS antisense RNA (non-protein 
coding) 
 
GNASAS 0.71 0.58 
hypothetical LOC100128163 
 
LOC100128163 0.84 0.73 
hypothetical LOC100130015 LOC100130015 0.65 0.41 
hypothetical LOC100130948 LOC100130943 
 
0.74 0.68 
hypothetical LOC100134361 
 
LOC100134361 0.64 0.62 
hypothetical protein LOC729683 LOC729683 0.73 0.44 
hypothetical protein MGC16121 MGC16121 0.75 0.42 
intercellular adhesion molecule 4 
(Landsteiner-Wiener blood group) 
ICAM4 0.68 0.52 
jumonji domain containing 7 JMJD7 0.75 0.56 
Kazal-type serine peptidase inhibitor 
domain 1 
KAZALD1 
 
0.58 0.21 
kelch domain containing 9 
 
KLHDC9 0.79 0.53 
leucine rich repeat and Ig domain 
containing 3 
LINGO3 0.54 062 
magnesium-dependent phosphatase 1 MDP1 
 
0.85 0.75 
NCK interacting protein with SH3 
domain 
NCKIPSD 0.77 0.60 
nestin NES 0.75 0.46 
neurofilament, medium polypeptide NEFM 0.67 0.36 
obscurin-like 1 OBSL1 0.70 0.51 
PDZ and LIM domain 7 (enigma) 
 
PDLIM7 0.87 0.68 
peroxisomal biogenesis factor 26 
 
PEX26 0.73 0.53 
phosphatidylinositol glycan anchor 
biosynthesis, class L 
 
PIGL 0.75 0.44 
polyamine oxidase (exo-N4-amino) PAOX 0.70 0.46 
potassium inwardly-rectifying channel, 
subfamily J, member 12 
KCNJ12 0.71 0.69 
proline dehydrogenase (oxidase) 1  PRODH 0.86 0.68 
proline-rich transmembrane protein 2  PRRT2 
 
0.72 0.51 
Putative uncharacterized protein 
ENSP00000385341 
 
 0.75 0.72 
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pyroglutamylated RFamide peptide 
receptor 
QRFPR 
 
0.83 0.69 
RAB26, member RAS oncogene family RAB26 0.43 0.44 
reprimo-like RPRML 
 
0.59 0.57 
secreted and transmembrane 1 SECTM1 0.70 0.45 
similar to hCG1804255 LOC100129794 0.88 0.62 
similar to hCG2039305 LOC729041 0.83 0.63 
SLIT and NTRK-like family, member 6 SLITRK6 0.60 0.39 
solute carrier family 22 (organic 
anion/urate transporter), member 11 
SLC22A11 0.63 0.17 
solute carrier family 25 (mitochondrial 
carrier; ornithine transporter) member 15 
SLC25A15 0.84 0.61 
stimulated by retinoic acid gene 6 
homolog (mouse) 
 
STRA6 0.69 0.37 
sulfotransferase family, cytosolic, 2A, 
dehydroepiandrosterone (DHEA)  
SULT2A1 0.66 0.59 
tetratricopeptide repeat domain 39A TTC39A 0.67 0.72 
transmembrane protein 107  TMEM107 0.86 0.68 
transmembrane protein 129 TMEM129 0.62 0.60 
transmembrane protein 80 TMEM80 0.69 0.76 
Treacher Collins-Franceschetti syndrome 
1 
TCOF1 0.64 0.38 
tripartite motif-containing 36 TRIM36 0.76 0.70 
Uncharacterized protein 
ENSP00000382042 
 0.84 0.19 
Yip1 domain family, member 2 YIPF2 0.76 0.61 
zinc finger protein 780A ZNF780A 0.78 0.62 
 
* Fold change: below 1 – down-regulated genes; above 1 – up-regulated genes  
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3. List of genes up-regulated in cells exposed to AZC or to canavanine 
 
Gene name Gene symbol 
AZC  
Fold 
Change(*) 
Canavanine 
Fold Change(*) 
AFG3 ATPase family gene 3-like 1 (S. 
cerevisiae)  
AFG3L1 1.24 1.46 
Bardet-Biedl syndrome 12  BBS12 1.21 1.32 
CD81 molecule  CD81 1.14 1.11 
cDNA FLJ23879 fis, clone LNG13743  
 
 1.38 2.05 
CDNA FLJ25625 fis, clone STM02974   
 
 1.24 1.44 
cDNA FLJ37880 fis, clone BRSTN2000220   1.28 2.20 
chromosome 1 open reading frame 198  C1orf198 1.19 1.45 
collagen-like tail subunit (single strand of 
homotrimer) of asymmetric 
acetylcholinesterase  
COLQ 1.54 1.47 
FSHD region gene 1 family, member B  FRG1B 1.17 1.28 
glucuronidase, beta pseudogene  GUSBP1 1.26 1.71 
guanylate cyclase 1, soluble, alpha 3  GUCY1A3 
 
1.24 1.46 
homeobox A4  HOXA4 1.10 1.58 
melanoregulin  MREG 1.22 1.30 
mitochondrial ribosomal protein L42 
pseudogene 5  
 
MRPL42P5 1.27 1.44 
paired box 6  PAX6 1.17 1.57 
SET domain containing 4  SETD4 
 
1.31 1.69 
SLIT-ROBO Rho GTPase activating 
protein 2  
SRGAP2 1.17 1.80 
sphingomyelin phosphodiesterase 3, 
neutral membrane (neutral sphingomyelinase 
II)  
SMPD3 1.42 1.50  
tuftelin 1  TUFT1 1.32 1.44 
zinc finger protein 320  ZNF320 1.20 1.63 
* Fold change: below 1 – down-regulated genes; above 1 – up-regulated genes  
 
